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Differential gene expression in two sexes is widespread throughout the animal 
kingdom, giving rise to sex-dimorphic gene activities and sex-dependent adaptability 
to environmental cues, diets, growth and development as well as susceptibility to 
diseases. This thesis presents a study using a toxicogenomic approach to investigate 
metabolic genes that show sex-dimorphic expression in the zebrafish liver triggered 
by several chemicals. The analysis revealed that, besides the known genes for 
xenobiotic metabolism, many functionally diverse metabolic genes, such as ELOVL 
fatty acid elongase, DNA-directed RNA polymerase, and hydroxysteroid 
dehydrogenase, were also sex-dimorphic in their response to chemical treatments. 
Moreover, sex-dimorphic responses were observed at the pathway level. Pathways 
belonging to xenobiotic metabolism, lipid metabolism, and nucleotide metabolism 
were enriched with sex-dimorphically expressed genes. The temporal differences of 
the sex-dimorphic responses were observed which suggested that both genes and 
pathways are differently correlated during different periods of chemical perturbation.  
 
Subsequently, the zebrafish toxicogenomic data and transcriptomic data from human 
toxico-pathological states were analyzed for the responses of male- and female-biased 
expressed genes. The analysis revealed obvious inverted expression profiles of sex-
biased genes, where affected males tended to up-regulate genes of female-biased 
expression and down-regulate genes of male-biased expression, and vice versa in 
affected females, in a broad range of toxico-pathological conditions. Intriguingly, the 
extent of these inverted profiles correlated well to the severity of toxico-pathological 
ix 
 
states which suggested that inverted expression profiles of sex-biased genes can be 
used as important indicators to assess biological disorders. The ubiquity of sex-
dimorphic activities at different biological hierarchies indicates the importance and 
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Chapter 1 Introduction 
 
Sexual dimorphism occurs at various biological levels throughout the life span of 
organisms that reproduce sexually, where males and females show obvious 
anatomical, physiological, and behavioral differences. These differences existing in 
male and female that benefit organisms under evolutionary selection in increasing the 
survival fitness of each sex [1]. Sexual recombination is thought to be important in 
releasing mutational meltdown caused by mutation accumulation [2]. It also acts as an 
adaptation mode of organism to resist parasite invasion [3-5] and response to 
environmental change [6]. 
 
Although sex-dimorphic traits are widespread across the animal kingdom, the 
knowledge about the mechanisms underlying of how these traits develop, evolve, and 
affect survival fitness is extremely limited [7]. Understanding how these traits 
differentially develop in two sexes is essential to unveil the genetic variation and 
molecular mechanisms that underlie their evolutionary path, as well as extreme 
helpfulness in elucidating the sex-related pathogenesis of various common disorders. 
To achieve this, it requires the understanding of both the species’ sex-determination 
system and the genetic networks that govern sex-specific development. 
 
In this thesis, my work mainly concerns elucidating sex-dependent gene expression 
profiles of zebrafish and how dimorphically expressed sex-biased genes were affected 
in both exposure to toxicants and pathological states. My major focus in this thesis 
 
 




concerned how chemicals induced sex-dimorphic genes under toxico-pathological 
conditions. In other words, there are two different sets of sex-dimorphic genes, one in 
normal physiology and one induced by toxicants. I will then describe how these 
chemical-induced sex-dimorphic genes were related to toxicity states. To fully 
illustrate the significance of this study, the following sections of the introduction are 
organized as follows. I first provide a general overview of sex determination systems 
to explain heterogeneous mechanisms in sex determination. This is followed by 
explaining the mechanism underlying differential gene expression among males and 
females and the molecular basis leading to sex differences for a number of cases. Sex 
differences in response to exogenous stress are also provided. Finally, molecular basis 
of xenobiotic metabolism, an important function that is known as a sex-dependent 
process is also given. 
 
1.1 Sex determination systems 
 
The sex determination system of a species comprises a cascade of cellular processes 
that determines the development of sexual characteristics in an organism. The animal 
sex determination systems are remarkably diverse which may involve either 
chromosomal (e.g. sex chromosomes) or environmental factors (e.g. temperature) as 








1.1.1 Chromosomal sex-determination (CSD) 
Chromosomal sex-determination (CSD) is the most extensively studied category of 
genetic sex-determination system. For most of the mammals, including human, sex is 
determined by the XX/XY system. In this system, females have homogeneous sex 
chromosomes that comprise two X chromosomes; males have heterogeneous sex 
chromosomes that comprise an X chromosome and a Y chromosome. As the variant 
of the XX/XY system, about twenty percent of animal species, such as the insect 
order Hymenoptera [8] and the Thysanopter [9], are estimated to use the haplodiploid 
sex-determination system [10]. For animals using the haplodiploid sex-determination 
system, sex is determined by the number of sex chromosomes in the genome. Males 
develop from unfertilized (haploid, X0: only one sex chromosome) eggs and females 
develop from fertilized (diploid, XX: two sex chromosomes) eggs. 
 
Sex for birds, on the other hand, is determined by the ZZ/ZW system. Females have 
one Z chromosome and one W chromosome, whereas males have two Z 
chromosomes. The Z chromosome is lager compared to the W chromosome, which is 
similar to the case in the XY system where X has more genes than the Y chromosome. 
Although the XY and ZW sex-determination systems are found to be used in different 
taxa and are thought to have evolved independently, a recent study comparing the 
platypus sex chromosome with the bird sex chromosome suggested an evolutionary 








Although there is an evolutionary conservation of sex chromosomes among phyla, the 
underlying genetic mechanisms that initiate the sex determination process varied 
substantially [12]. For animals with XX/XY system, the male-dominate gene Sry 
(sex-determining region Y) on the Y chromosome has been identified to gives rise to 
the development of the embryonic undifferentiated gonad into a testis [13]. 
Subsequently, the testis begins producing testosterone and other necessary hormones 
which induce the formation of other organs in the male reproductive system [14], and 
male-specific gene activity in other tissues. Absence of the Sry gene results in the 
development of gonad to the ovary. However, the Sry gene is not found in the genome 
of other vertebrates such as birds that use ZZ/ZW system [15]. Instead, the Z-linked 
gene Dmrt1 (doublesex and mab-3 related transcription factor 1) is recognized to be 
the avian species’ sex determining gene [16, 17]. 
 
In phyla of lower invertebrates, other genetic cues of sex determination are identified. 
For model animal Drosophila melanogaster (fruit fly), the sex-specific RNA splicing 
produces the male-specific isoform of Dsx
M
 (doublesex) and Fru
M 
(fruitless), and the 
female-specific isoform of Dsx
F
, which are the major regulators of the downstream 
sex-specific cellular process [18]. For honeybee A. mellifera, sex determination is 
initiated by Csd (complementary sex determiner) gene [19], successively, induces the 









Although the genetic cues which initialize sex determination process are varied for 
different species, the downstream regulation has reported to converge to the 
conserved genes and pathways [7, 20]. For example, some broadly conserved sex-
determination related genes, such as Dmrt1 (doublesex and mab-3 related 
transcription factor 1), Dsx (doublesex), Dmy (Y-specific DM-domain gene), and 
Mab-3 (male abnormal 3), have a common DNA binding motif called DM domain 
[21-23].The DM domain-related proteins function as regulatory factors on the same 
downstream transcriptional activities [24, 25]. 
 
1.1.2 Polygenic sex determination (PGSD) and Environmental sex determination 
(ESD) 
Unlike chromosomal sex determination (CSD) system where sex is determined by a 
primary switch such as Sry gene located on the Y chromosome, in polygenic sex 
determination (PGSD) system, sex is determined by the combination of a number of 
genes distributed throughout the genome [26]. The PGSD system is less studied but 
has been reported to be used in few species, including fish such as Mendidia menidia 
[27], zebrafish (Danio rerio) [28-30], European seabass [31], the parasitic wasp 
Nasonia vitripennis [32], the turtles Graptemys ouachitensis [33], and Chelydar 
serpentine [34]. 
 
Other than genetic factors, sex determination and differentiation of some species, for 
example fish, amphibian, and reptile, are closely connected to environmental cues. 
There are many environmental factors which are potentially able to impact the 
 
 




offspring sex, among which temperature has recognized as the one of the most 
important environmental cues [35-37]. Temperature-dependent sex determination 
(TSD) has been extensively studied in reptiles [6]. For example, exposure to higher 
incubation temperature results in female development in some species of turtles [38]. 
The mechanisms of temperature effects on sex determination are mediated by 
influencing aromatase activity which disturbs biosynthesis of sex hormone, acting on 
steroidogenic enzyme-coding genes and hormone receptors [39, 40], as well as 
directly affecting the expression of Sry-related (Sox) gene in a reptile [41].  
 
A recent study revealed the adaptive benefit of temperature-dependent sex 
determination to the species [42]. The specific incubation temperature, which gives 
rise to male offspring, also endows the maximal reproductive fitness to males. In 
contrast, the temperature, which gives rise to female offspring, endows maximal 
reproductive fitness to females. 
 
1.1.3 Zebrafish sex determination and sexual differentiation 
Zebrafish has been used as important laboratory model organism, however, limited 
information is known about its sex determination and sexual development (see review 
[43]). The diploid genome of zebrafish consists of 50 chromosomes, but there are no 
morphological differences in the chromosomes between two sexes (sex chromosomes) 
have been identified [44]. It also has been shown that environmental factors impose 
limited influence on the zebrafish sex ratio within the physiological range of the 
species, thus, should not be a primary factor for the zebrafish sex determination [28]. 
 
 




A summary of these studies indicates that zebrafish sex determination is probably 
mediated by genetic signals from autosomes. 
 
A number of genes such as Ftz-f1 (Fushi Tarazu factor-1), Sox9 (SRY HMG box 
related gene 9), Wt1 (Wilms tumor 1), Amh (anti-Mullerian Hormone), Dmrt1 
(doublesex and mab-3 related transcription factor 1), Gata4 (GATA-binding protein 
4), Ar (androgen receptor), FIGalpha (factor in the germline alpha), and Cyp19a1a 
(cytochrome P450, family 19, subfamily A, polypeptide 1a) have been prove to 
associate with the processes of  zebrafish sex determination and differentiation [44, 
45]. However, no evidence indicates that any of these genes alone is sufficient to 
determine the sex of zebrafish. Instead, all of those genes are the components of a 
signaling network which involves in the determination and development of sex-
specific gonads [44]. Therefore, it is suggested that zebrafish has a polygenic sex 
determination system [28]. 
 
Currently, knowledge about sex development of zebrafish is mainly centered on 
gonad differentiation (see review [44, 46]). Regardless of the genetic background, 
zebrafish is default to develop ovary-like gonads prior to sex differentiation [47]. 
Ovarian development is initiated at approximately 10 days post fertilization (dpf) and 
progresses until 20 dpf. At 20 dpf until approximately 30 dpf testis development is 
initiated in males simultaneously with ovarian cell apoptosis [44, 47]. Zebrafish is 








1.2 Sex-dimorphic gene expression 
 
For the same species, males and females are almost genetically identical except few 
genes located on sex chromosomes (e.g. Sry gene on the Y chromosome of mammals 
presents only in male, but not in female), which means that the sex-dimorphic traits 
indeed arise from the sex-dependent expression of genes present in both male and 
female [49, 50]. A gene with sex-dimorphic expression is termed a sex-biased gene. 
Sex-biased genes can be further categorized into male-biased and female-biased genes, 
which are exclusively expressed or with higher level of expression in males and 
females, respectively. 
 
A substantial number of genes showing sex-dependent expression have been 
demonstrated to be present in a wide range of taxa. For example, there are more than 
57% genes exhibiting sex-biased expression in the Drosophila melanogaster genome 
[51].  One recent meta-analysis identified more than ten thousand of sex-biased genes 
in mice by employing large number of samples to distinguish relatively small 
difference in gene expression between sexes [52]. Furthermore, thousands of genes 
were also identified to be sex-biased activated in nematode Caenorhabditis elegans 
[53-55]. These studies suggest the wide extent of sex-dimorphic gene expression in 
cell, which is much greater than previously recognized. In addition, genes with sex-
biased expression were typically expected to be enriched on sex chromosomes (X and 
Z chromosomes) [56, 57]. However, a recent study revealed the enrichment of the 
sex-biased genes on autosomes as well [52]. 
 
 




Sex-biased genes have principally been examined in gonads due to the secretion of 
sex hormones in gonadal tissues [58-61]. Nevertheless, recent studies indicated the 
widespread expression of sex-biased genes in many somatic tissues. For instance, 
several cytochrome P450 enzymes are differentially expressed between two sexes in 
the rat liver [62, 63]. One study also identified 27 sex-specific gene expressions in the 
mouse kidney (> 3 fold change) [64]. A high degree of sex-dimorphic gene 
expression in the brain were observed in two species of songbirds,  the zebra finch 
(Taeniopygia guttata) and the common whitethroat (Sylvia communis), [65], and the 
zebrafish (Danio rerio) [66]. In addition, 13 genes in mice heart and 14 in humans 
heart were also identified as being expressed in a sex-dependent manner with a 
greater than 2 fold change [67].  
 
Through the meta-analysis with statistical power to detect minor changes in gene 
expression between the sexes, Yang et al. detected 9250, 11336, 4083, and 612 sex-
biased genes (> 1 fold change and p-value < 0.01 for Wilcoxon test) in liver, adipose 
tissue, muscle, and the brain, respectively [52]. By comparing the sex-biased genes 
among four tissues, however, only 27 genes were dimorphically expressed in all four 
tissues indicating the highly tissue-specific gene set with sex-dimorphic expression. 
Moreover, the transcriptional factor binding sites of the sex-biased genes were also 









Taken together these reports suggests that sexual dimorphism which stems from sex-
dependent genetic and hormonal regulation at the cellular level is widespread across 
many, if not all, organs. Thus, these findings emphasize the significance of including 
sex as a major consideration in biomedical researches, since the extensive sex-
dependent gene expression may induce sex-related toxico-pathological differences 
from the disturbance of other genetic, environmental or experimental factors. 
 
1.3 The basis for sex difference 
 
Sexual dimorphism of animals begins early during embryonic development and 
remains throughout the lifespan. The nature of the mechanisms underlying observed 
sex differences has been suggested on the combination of genetic and hormonal 
actions in animals, but, continues to be debated. 
 
1.3.1 Central dogma of sexual differentiation (hormonal view) 
The central dogma of sexual differentiation was established stemming from gonad-
transfer experiments done by Alfred Jost [68]. Removal of the mammalian 
undifferentiated embryonic gonad causes embryos to develop as females despite the 
genetically male (XY) or female (XX), demonstrating the essential roles of gonad and 
gonadal hormone secretion to male development. According to this viewpoint, sex-
dimorphic traits are dependent primarily on sex hormone secretions from the 
differentiated gonads. Presence of testes induces male development through the 
actions of testicular hormones, while the absence of testes and testicular hormones 
 
 




results in female development. Therefore, sex determination is typically considered 
equivalent to gonadal determination in mammals [69]. 
 
Subsequent studies have demonstrated the influence of gonadal hormones on somatic 
tissue development and organismal behavior. For example, when testosterone was 
administered to pregnant female guinea pigs, profound effects on sexual behavior 
were observed both in the pregnant female and their female offspring [70]. 
Testosterone permanently masculinized and defeminized female guinea pig 
copulatory behavior patterns, as female offspring were more likely to display 
masculine mounting behaviors compared to normal females. The neuron number in 
some regions of central nervous system can be sex-reversed by treating females with 
male sex hormone, or inhibiting the activity of testicular hormones in males [71]. 
Studies also revealed that the morphology of some areas in the brain and neuronal 
enzyme activities are directly related to the sex hormone exposure at some specific 
developmental time point [72, 73]. 
 
Other than sex hormones, e.g. androgen and estrogen, the plasma growth-hormone 
(GH) profiles are also found to be different in male and female [74, 75]. The sex-
dimorphic pattern of plasma growth hormone (GH) profiles was suggested to play a 
key role in sex-dependent hepatic gene expression [76-78] involving the gene Stat5b 
(signal transducer and activator of transcription 5b) through the signal transduction 
pathways [79]. In male rodents and humans [80-83], the secretion of growth hormone 
is in a pulsatile manner with discrete peaks of plasma growth hormone levels. On the 
 
 




other hand, the female has a near continuous concentration of growth hormone in 
plasma [84]. The activation of Stat5b is strongly associated with plasma growth 
hormone pattern inducing repeated cycles of liver Stat5b in adult male rats and mice 
and the persistently low levels of Stat5b in female [84-87]. 
 
Both sex steroid hormones and growth hormones introduce different chemical 
environments to male and female cells and tissues that persist into adulthood. The 
differences of hormonal milieu in male and female are also suggested to explain the 
sex-dependent differences in the appearance, susceptibility, and severity of human 
diseases [88-91]. 
 
1.3.2 Genetic factors independent of hormones 
Different hormonal profiles, e.g. androgens, estrogens, and growth hormone, are 
generally accepted as the primary basis for sex-dimorphic development of animals 
and human. However, a key question rises about whether genetic factors, other than 
hormonal effects, contribute to sex differences [92]. The exclusively hormonal dogma 
has been challenged by recent studies on hormone-independent sex differences in 
somatic tissues and some molecular processes [69, 93-102]. 
 
There are several examples which clearly demonstrated the hormone-independent 
sexual dimorphisms caused by genetic factors. Robert J. Agate et al. reported a study 
of the brain of a rare gynandromorphic finch [97] which is genetically male for one 
 
 




half of its brain and body (cells with two Z sex chromosomes), and genetically female 
for the other half of the body (cells with one Z sex chromosome and one W sex 
chromosome). In normal finch, males have larger neural song nuclei and relevant 
neurons because they sing a courtship song for attracting females [99]. For this rare 
gynandromorphic finch, both the left and right cerebral hemisphere of the brain was 
developed in the same hormonal environment. If biological characteristics and brain 
structure are completely determined by the hormones, the morphology of the song 
circuit on both cerebral hemisphere of the gynandromorphic finch brain would be 
equally masculine or feminine. However, an examination of the brain showed that 
neural song circuit of the genetically male side had a more masculine phenotype than 
that of the other side (genetically female). Therefore, the differences between two 
halves of the gynandromorphic finch brain indicate that the genetic sex also 
contributes to sexual differentiation of the brain. 
 
In another study, the female Japanese quail forebrain primordium, which was 
gathered from embryos before gonadal differentiation, was transplanted to a male 
body (i.e. female donor-to-male host) [98]. If brain development occurs in the 
presence of gonadal hormones, then female brains in male bodies should develop into 
male brains (host-typical development). However, the male body Japanese quails with 
female brains (female donor-to-male host) did not develop to the entirely male-like 
neural and behavioral phenotypes, even if the female forebrain primordium is exposed 








Evidences of hormone-independent sexual dimorphisms have accumulated in many 
taxa. For example, sexual reversal of gonads in female whiptail lizards does not lead 
to the male-like change of limbic nuclei size [100]. Study of gynandromorph blue 
crab (bilaterally divided into genetically male for one half of its body and genetically 
female for another half of its body) revealed that a small metabolite, 2-aminoethyl 
phosphonate, has much higher concentration in the male side gill than in the female 
side grill indicating the sex-specific synthesis and activation of enzyme system [102]. 
Therefore, genetic factors play a significant role in sex differences in animal 
development which combines with the differential secretion of gonadal hormones in 
the two sexes producing various sex-dimorphic traits and behaviors. 
 
1.4 Sex-related differences in response to exogenous stress 
 
Due to the different strategies adopted to maximize survival fitness, exogenous 
perturbations induced by environmental factors, disease, and even psychosocial stress, 
typically trigger striking disparity of endogenous alterations, phenotypic and 
behavioral variations in the two sexes. This is evidenced by the increasing acceptance 
that males and females differ in susceptibility to diseases, vulnerability to 
pharmaceuticals in terms of drug efficacy and adverse drug reactions, as well as 
differential responsiveness to real-life stressors [88-91, 103-110]. 
 
Sex-dependent responses to exogenous perturbations are deemed to originate from the 
differential secretion of gonadal hormones and sex-biased gene expression in male 
 
 




and female. Although hormonal and transcriptomic differences between two sexes 
and their impact on genetics, morphology, and behavior of organisms are well 
documented under normal physiology, there is still limited information of sex-
dependent gene responses to exogenous perturbations such as environmental 
contaminators [111]. 
 
1.4.1 Sex-related differences in exposure to environmental toxicants 
Humans and animals are constantly exposed to potentially harmful chemicals within 
their living habitats. Since the existing sex-related gene expression and hormonal 
milieu, male and female exhibit differential susceptibility and responses to chemicals 
that perturb normal cellular homeostasis at various life stages [112]. Currently, 
common environmental toxicants are mainly produced from automobile emission, 
industrial and agricultural pollution, which include pesticides, herbicides, volatile 
organics, heavy metals, etc.  
 
Environmental pollutants can cause a broad spectrum of harmful effects to animals, 
which depend on both the route of exposure and the exposure dosage. The 
susceptibility to xenobiotic chemicals and the severity of chemical-induced tissue 
injury are influenced by a great variety of exogenous and endogenous factors, such as 
body size, host age, and genotype, etc., among which the gender factors are not taken 
into serious consideration in relevant research [113-115] thus far. Thus, understanding 
the association between sex traits and chemical-induced disruption to normal 
 
 




biological functions will have great impact in both toxicological and biomedical 
researches [116]. 
 
1.4.2 Endocrine disrupting chemicals (EDCs) 
Some environmental chemicals can influence normal hormonal synthesis, secretion, 
and transmission. The altered endocrine system subsequently affects downstream 
cellular processes. These chemicals are characterized as endocrine disrupting 
chemicals (EDCs) which cover a wide range of industrial materials including 
Polychlorinated biphenyls (PCB), Dichloro-diphenyl-trichloroethane (DDT), 
Bisphenol A (BPA), and heavy metals [117, 118]. Exposure to endocrine disrupting 
chemicals has been recognized to pose differential influences between two sexes in 
various stages of lifespan, leading to sex-biased chemically induced developmental 
disorders, birth defects, perturbations of adult reproduction, and even cancerous 
tumors [112]. 
 
Endocrine disrupting chemicals can act either as agonists or antagonists to hormone 
and hormone receptor (i.e., chemical is either androgenic or estrogenic). If females are 
exposed to androgenic EDC, the EDC will generally masculinize or defeminize 
female traits and behaviors. If the EDC is estrogenic, such as androgen receptor (AR) 
antagonist or androgen synthesis inhibitor, it can disturb the synthesis and activity of 
endogenously produced testosterone and dihydrotestosterone (DHT) which might 








For example, heavy metal cadmium is an estrogenic EDC that has been proved to 
inhibit progesterone synthesis in Sprague-Dawley rats [119], reduce gene 
transcription of estrogen receptor (ER) and increase gene expression of the 
progesterone receptor (PR) in the human breast cancer MCF-7 cell line [120]. It 
indicates that cadmium can exert the estrogenic effect both in vivo and in vitro. 
Another heavy metal, arsenic, is also suggested to interact with endocrine system in 
arsenic-related toxicity [121]. Jana et al. [122] reported an estrogen-mimicking 
activity of arsenic inducing testicular toxicity in adult male rats by inhibiting 
androgen production. In an in vitro system, human breast cancer cell line MCF-7, 
arsenite caused the decrease of estrogen receptor-alpha expression and the increase of 
progesterone receptor expression [123]. Besides the heavy metals, the day-to-day used 
drugs, such as the fungicide vinclozolin, can also impose endocrine disrupting effects 
to animals [124]. 
 
Since not all sex differences are attributable to hormones [125], mounting evidence 
suggests that sex-related toxic effects of xenobiotics, such as those induced by 
environmental pollutants and pharmaceuticals, might not necessarily interact with the 
endocrine system, but rather directly induce sex differences on genetic factors [126]. 
 
1.5 Xenobiotic metabolism 
 
Metabolism plays a key role in the detoxification of exogenous xenobiotics. 
Xenobiotic metabolism includes several phases of biotransformation processes, i.e. 
 
 




Phase I xenobiotic modification and Phase II conjugation, which were firstly proposed 
by Williams [127], and Phase III further modification and excretion. 
 
Phase I xenobiotic metabolism includes processes such as oxidation, reduction, and 
hydrolysis. The most extensively studied process in Phase I xenobiotic metabolism is 
the mono-oxygenation function catalyzed by the cytochrome P450s [128]. These 
enzyme complexes function via inserting one atom of oxygen into the organic 
substrate, introducing  hydroxyl groups or N-, O- and S-dealkylation of substrates 
[129]. Phase II xenobiotic metabolism catalyzed often by the “transferase” enzymes, 
e.g. UDP-glucuronosyltransferases (UGT), comprises conjugation reactions such as 
glucuronidation, sulfation, and methylation. The products of phase II conjugations are 
typically less toxic and more hydrophilic than the parent compounds and therefore 
usually more readily to be excreted [128]. Phase III biotransformation is a more newly 
coined descriptor that refers to active membrane transporters that function to shuttle 
drugs and other xenobiotics across cellular membranes [128]. 
 
Xenobiotic metabolism has been reported to be differentially exerted in male and 
female animal by means of sex-dependent gene expression and enzyme activity. 
There are many studies reported the sex-dimorphic activities of enzymes involving in 
phase I xenobiotic metabolism. For example, a major drug metabolizing enzyme 
Cyp3a4 has higher average activity in women comparing with men in the liver, 
nevertheless, other cytochrome P450s, such as Cyp2d6, exhibit higher activity in men 
than women [130]. In mice, the flavin-containing mono-oxygenase, Fmo1 is twice as 
 
 




active in female liver, whereas Fmo3 is only present in female liver [131]. Similarly, 
in the mouse kidney, flavin-containing mono-oxygenase 5 (Fmo5) in expressed four-
fold higher in males than in females [132]. Furthermore, phase II xenobiotic 
metabolism is also demonstrated to have sex-dependent activity. The sulfatases and 
sulfotransferase are differently activated between male and female rats [133]. In 
guinea pigs, female sex hormones have been proven to inhibit glucuronyl transferase 
[134]. 
 
The differential xenobiotic metabolism between the sexes, including both phase I and 
phase II biotransformation, have been well-documented. However, less is known 
about either the molecular mechanisms prompting downstream transcription during 
xenobiotic encounter or identities with sex-related responses emerging from other 
parts of metabolism. As aberrant metabolic states are known to sexually associate 
with metabolic-related syndromes and diseases, such as obesity, type 2 diabetes, and 
cardiovascular diseases [135-138], this implies that chemical-induced sexual 
dimorphic toxicopathology in metabolic-related genes are also relevant. 
 
1.6 Liver as the major target organ of chemical toxicity and the 
primary organ in detoxification 
 
Detoxification, which is the process to remove hazardous xenobiotics from living 
organisms, is critical in maintaining health. For vertebrates, liver is an indispensable 
organ in detoxifying toxic substances. For example, the liver has been reported to be 
 
 




the major target organ of arsenic toxicity in both mice [139, 140] and human [141-
143]. This indicates that the liver is an ideal candidate to study homeostatic processes 
in response to xenobiotic insults. 
 
Many hepatic genes exhibit sex-dimorphic expression under normal physiology in 
mice [52]. More importantly, studies also showed that genes associated with 
xenobiotic metabolism, such as those encoding cytochrome P450 enzymes, are 
differentially expressed between the sexes in the liver of rodents [62, 63, 144] and 
human [145, 146]. Since cytochrome P450 enzymes are a family of proteins 
responsible for metabolizing xenobiotics, the differential expression of cytochrome 
P450 genes in male and female is likely to affect the rate of xenobiotic metabolism. 
 
A few studies have reported relevant findings about sex-dimorphic xenobiotic 
metabolism. For example, the different clearance rate of more than 31 drugs 
metabolized by Cyp3a family is observed between women and age-matched men [126, 
147-150]. In addition, hepatic metabolism in some reptiles (i.e., male and female 
alligators) exposed to environmental chemicals also exhibit sex-specific differences 
[151]. Taken together these reports suggest chemical insults can induces sex-










1.7 Objective and outline of this thesis 
 
1.7.1 Objective of this thesis 
The goal of this thesis is to investigate the sexual dimorphism on the transcriptomic 
level induced by exogenous perturbations such as chemical exposure and disease, and 
to identify the dimorphically behaved genes and pathways among the two sexes. In 
order to achieve this goal, the computational analysis on the gene expression profiles 
of chemical-treated male and female zebrafish was carried out. The analysis of sexual 
dimorphism also extended to the data of human diseases, as they may have 
implications for toxicological and pathological disorder. 
 
First, the role of sex on global gene expression profiles under toxico-pathological 
states was examined. Several chemical-diverse toxicants were used to disturb the 
normal physiological homeostasis in zebrafish from early to prolonged time of 
treatment. The disturbed transcriptomic profiles were compared between male and 
female fish. In this way, the sex-dimorphic response of genes and pathways and their 
corresponding biological functions can be identified at different stages of chemical 
treatment. 
 
Subsequently, the sex-biased orientation of gene was investigated. The comparison of 
sex-biased gene (male-biased and female-biased) under normal physiology and 
toxico-pathological states can illustrate different regulatory disorder in two sexes. 
Then, the computational analysis was extended to the transcriptomic profiles of 
 
 




humane diseases that the possible conservation of sex-dimorphic response between 
fish and mammal might implicate the potential application in biomedical studies. 
 
1.7.2 Outline of this thesis 
In Chapter 1, an overview of the sexual dimorphism in organisms was given. First 
various sex determination systems were introduced, which followed by a review of 
sex-dimorphic gene expression in animals under both normal physiology and toxico-
pathological states. The current understanding of hormonal and genetic contributions 
to sexual dimorphism was presented in section 1.3. Then the process of xenobiotic 
metabolism and the sex-related detoxification in liver were presented. 
 
Chapter 2 demonstrated the transcriptome datasets used in this thesis, which were 
provided by my collaborators and collected from public database. Then, the processes 
of raw data normalization and transformation were described, which followed by the 
identification of sex-dimorphic and responsive genes. 
 
In Chapter 3, the statistical and computational approaches were introduced which 
included using the bioinformatics database for metabolic function classification, the 
bioinformatics tools such as hierarchical clustering and enrichment analysis, the self-
devised algorithm for the specific scientific problem, and pathway network 








Chapter 4 discussed the computational analysis of sexual-dimorphically behaved 
genes and pathways in the chemical-treated zebrafish. The self-devised algorithm was 
used to identify genes with commonly sex-dependent response under different 
chemical treatments. Then the pathway analysis was performed to detect the 
coordination of these genes at the metabolic pathways and higher level of pathway 
network. 
 
In Chapter 5, the inverted expression profiles of sex-dimorphic genes induced by 
chemical treatment in zebrafish liver were analyzed. In order to examine the 
phenomena in higher order animals, the analysis was extended to the transcriptomic 
profiles of several human diseases. 
 
In the last chapter, Chapter 6, the major findings and contributions of current work to 
sex-dimorphic gene expression study were discussed. Limitations of current work and 
suggestions for future studies are also stated in this chapter. 
 
 
Chapter 2 Microarray datasets, raw data processing, and 
identification of significant genes 
 
2.1 Microarray datasets 
 
To investigate sex-dependency to various toxico-pathological and disease conditions, 
the zebrafish was used as a model to study sex-dependent response to toxicants. The 
DNA microarray experiments were performed by my collaborators in Prof. Gong 
Zhiyuan’s lab from the Department of Biological Sciences at the National University 
of Singapore to screen the zebrafish hepatic transcriptome profiles under toxic 
conditions (for details of wet lab experimental protocol, please refer to Appendix A). 
In addition, we also retrieved public transcriptome data from Gene Expression 
Omnibus (GEO) for the association of sex to human diseases. 
 
2.1.1 Zebarfish hepatic transcriptome profiles under toxic conditions 
The zebrafish hepatic transcriptome profiles are used here by permission of Prof. 
Gong Zhiyuan’s lab (http://www.dbs.nus.edu.sg/staff/gong.htm). Table 1 summarized 
the transcriptomic data which includes the concentrations of chemicals, number of 
replicates of each experiment, and the GEO accession of the microarray data. Both 
male and female zebrafish were treated with cadmium (II), arsenic (V), 4-
chloroaniline (CA), and 4-nitrophenol (NP), that the liver tissue was sampled at four 
time points (8, 24, 48, and 96 hours). All microarray data generated is MIAME 
compliant. 
  




Table 1. Categories and types of zebrafish hepatic transcriptome data.  
CA = 4-Chloroaniline; NP = 4-Nitrophenol; As = Arsenic (V); Cd = Cadmium (II). 
Sample Label  Treatment Conditions   GEO Series Accession #of 
replicates 
CA_8h_Female  20 mg/L, 8h, female fish   GSE30057  3 
CA_24h_Female  20 mg/L, 24h, female fish   GSE30057  3 
CA_48h_Female  20 mg/L, 48h, female fish   GSE30057  3 
CA_96h_Female  20 mg/L, 96h, female fish   GSE30057  3 
CA_8h_Male  20 mg/L, 8h, male fish   GSE30055  3 
CA_24h_Male  20 mg/L, 24h, male fish   GSE30055  3 
CA_48h_Male  20 mg/L, 48h, male fish   GSE30055  3 
CA_96h_Male  20 mg/L, 96h, male fish   GSE30055  3 
NP_8h_Female  7 mg/L, 8h, female fish   GSE30060  3 
NP_24h_Female  7 mg/L, 24h, female fish   GSE30060  3 
NP_48h_Female  7 mg/L, 48h, female fish   GSE30060  3 
NP_96h_Female  7 mg/L, 96h, female fish   GSE30060  3 
NP_8h_Male  7 mg/L, 8h, male fish   GSE30058  3 
NP_24h_Male  7 mg/L, 24h, male fish   GSE30058  3 
NP_48h_Male  7 mg/L, 48h, male fish   GSE30058  3 
NP_96h_Male  7 mg/L, 96h, male fish   GSE30058  3 
As_8h_Female  15 ppm (~192 µM), 8h, female fish  GSE30062  3 
As_24h_Female  15 ppm (~192 µM), 24h, female fish GSE30062  3 
As_48h_Female  15 ppm (~192 µM), 48h, female fish GSE30062  3 
As_96h_Female  15 ppm (~192 µM), 96h, female fish GSE30062  3 
As_8h_Male  15 ppm (~192 µM), 8h, male fish  GSE3048  3 
As_24h_Male  15 ppm (~192 µM), 24h, male fish  GSE3048  3 
As_48h_Male  15 ppm (~192 µM), 48h, male fish  GSE3048  3 
As_96h_Male  15 ppm (~192 µM), 96h, male fish  GSE3048  3 
Cd_8h_Female  30 μg, 8h, female fish   GSE41622  2 
Cd_24h_Female  30 μg, 24h, female fish   GSE41622  3 
Cd_48h_Female  30 μg, 48h, female fish   GSE41622  3 
Cd_96h_Female  30 μg, 96h, female fish   GSE41622  2 
Cd_8h_Male  30 μg, 8h, male fish   GSE41623  2 
Cd_24h_Male  30 μg, 24h, male fish   GSE41623  2 
Cd_48h_Male  30 μg, 48h, male fish   GSE41623  3 
Cd_96h_Male  30 μg, 96h, male fish   GSE41623  3 
  




2.1.2 Transcriptome profiles in human diseases 
The transcriptomic profiles in human diseases, together with their respective Gene 
Expression Omnibus (GEO) series accession, are summarized in Table 2, that were 
collected from 9 published microarray series in GEO which covered 9 different 
human tissues and 17 distinct pathological cases [152-160]. 
 
Table 2. Summary of microarray data of human diseases. 
GEO Series 
Accession 
Data Description Organ/Tissue Reference 
GSE3467 Papillary Thyroid Carcinoma Thyroid tissues [152] 
GSE4107 Colorectal Cancer Colonic mucosa [153] 
GSE5081 
Gastric Helicobacter pylori 
Infection 
Gastric biopsy [154] 
GSE7621 Parkinson's Disease Substantia nigra tissue [155] 
GSE10135 






Adenoma and Adrenocortical 
Carcinoma 
Adrenal cortex [157] 
GSE11348 Rhinovirus Infection Nasal scrapings [158] 
GSE11882 
Aging in Entorhinal Cortex, 
Hippocampus, Postcentral 






















2.2 Microarray data normalization and transformation 
 
2.2.1 LOWESS normalization 
In microarray experiment, the reference and sample RNAs were labeled using 
fluorescent dyes Cy-3 (Green) and Cy-5 (Red). Then the expression of sample RNA 
on top of reference is represented by the value of 
2log ( / )R G . However, several 
reports have indicated that there is a systematic dependence of the 
2log ( / )R G  value 
and dye intensity [161, 162]. It can be visualized by plotting the 
2log ( / )R G value as a 
function of the dye intensity 2log ( )R G for each gene in a scatterplot. Therefore, the 
Lowess normalization, which bases on the locally weighted regression and smoothing 
scatterplots [163], is used to remove the intensity-dependent effect [164]. 
 
In Lowess normalization, a number of closest neighbors to each data point of 
observation are involved for the local polynomial regression using weighted least 
squares. The weight of each neighbor is calculated according to its distance from the 
data point of observation. Then the adjusted value of 2log ( / )i iR G from i th data point 
on the scatterplot is corrected by the following adjustment: 
2 2 2log ( / ) log ( / ) (log ( ))i i i i i iR G R G f R G
     
where 
2log ( / )i iR G
  is the corrected value, 2(log ( ))i if R G is the Lowess fit at the i th 
data point. These steps are carried out for every data of observation in the 2log ( / )R G
-- 2log ( )i iR G  scatterplot. 
  




2.2.2 Z-score normalization 
Before comparing the microarray data generated from different experiments, the 
microarray data of individual experiment must be normalized with respect to each 
other in order to account for experimental variation in RNA amounts, specific activity 
of DNA labels, and standard handling errors. The Z-score normalization provides a 
way of standardizing data across different experiments and allows the comparison of 
microarray data independent of the original hybridization intensities [165]. 
 
Raw microarray data for each experiment is firstly transformed by logarithmic 
function, and the transformed data were used for the calculation of Z scores. Z score 
indicates how much the observed data diverges from the mean in the unit of standard 







2.2.3 Microarray data processing 
The raw microarray data was normalized using Lowess method [161] in the R 
package (http://www.braju.com/R/). The zebrafish genes were mapped to human 
homologous genes as described previously [166] and was subsequently used to map 
with metabolic genes defined in the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) database [167] (for details of KEGG database please refer to section 3.1, 
Chapter 3). Student’s t-test was performed to evaluate statistical significance 
between treatments and controls. Each gene was assigned with the value of log10(1/P) 
  




where P is the p-value of a gene obtained from Student’s t-tests. Z-score 
normalization [165] (for details of Z-score normalization please refer to section 2.2.2) 
was performed to standardize the value of log10(1/P) for each gene with respect to 
each chemical treatment to enable the comparison of microarray data generating from 
different experiments. 
 
2.3 Identification of sex-dimorphic and responsive genes 
 
2.3.1 Identification of chemical-induced sex-dimorphic genes 
To identify chemical-induced sex-dimorphic genes, which respond differently in male 
and female under toxicant insults, arrays from the same sex of the chemical treated 
states were firstly compared against their respective control group (applying the 
microarray data processing technique in last section) to assess how genes were 
perturbed. Next, the perturbed male genes were compared with corresponding female 
genes by a computational algorithm (for details, please refer to section 3.4, Chapter 3) 
to determine whether a chemical can induce sex-dimorphic gene expression (Figure 
1). 
  





Figure 1. Identify chemical-induced sex-dimorphic genes 
 
2.3.2 Identification of sex-biased genes (male-biased and female-biased) under 
normal physiology 
From the view point of sex-dependent activity of genes, all the expressed genes within 
an individual can be categorized as either sex-dimorphic or non-sex-dimorphic, with 
genes showing differential expression or no difference in expression between two 
sexes. Sex-dimorphic genes can be further categorized into male-biased or female-
biased genes, whose expression was significantly biased in males and in females, 
respectively. For each transcriptomic experiment, controls are referred to untreated 
healthy individuals. For a respective GEO series, arrays of control males were 
compared against arrays of control females. Student’s t-test was used to access 
statistical significance for genes that were differentially expressed in males or females. 
Genes showing p-value < 0.01 with increased expression levels were defined as male-
biased genes. Similarly, genes with p-value < 0.01 with decreased expression levels 
  




were defined as female-biased genes (Figure 2). Both zebrafish and human data were 
similarly processed to obtain their respective sex-dimorphic genes. 
 
Figure 2. Identify sex-biased genes under normal physiology 
 
2.3.3 Identification of toxicant or disease responsive genes  
To determine genes that were affected under a toxicological or a disease state, arrays 
from the same sex of the treated or diseased states were compared against their 
respective control group. For instance, arrays of arsenic-treated male zebrafish were 
compared against untreated male fish in the same experiment to identify genes that 
were deregulated by arsenic in males. Female data were similarly processed, i.e., 
treated female fish were compared against untreated female fish. The same procedure 
was also applied for human data. Genes showing p-value < 0.01 from the Student’s t-
test were considered significantly affected, with those expressed at higher or lower 
amounts as up- and down-regulated genes, respectively (Figure 3).   
  









Chapter 3 Bioinformatics database and computational 
approaches  
 
3.1 Kyoto Encyclopedia of Genes and Genomes (KEGG) database 
 
The wide usage of high-throughput experimental technologies, such as DNA 
microarray and genome sequencing, in biological study has been generating a huge 
amount of molecular data sets than ever before. Therefore, it is even more important 
to organize the rapidly increasing biological data into well-structured database that 
can be easily retrieved and interpreted. Kyoto Encyclopedia of Genes and Genomes 
(KEGG, http://www.genome.jp/kegg or http://www.kegg.jp/) is one of the most 
widely used biological databases that integrates information about genes, proteins, 
biochemical compounds and reactions, and biological pathways [167]. 
 
The information on metabolism was retrieved from KEGG database for further 
analysis in this thesis. The knowledge of metabolites (chemical compounds) and 
biochemical reaction that combined to construct metabolic networks for various 
species [168] which have also been applied to study the gene essentiality in one of our 
works [169]. KEGG database also offers detailed information about genes involving 
each metabolic pathway. The metabolic category contains different hierarchies of 
metabolism, such as carbohydrate metabolism, lipid metabolism, and amino acid 
metabolism. This is a prerequisite for pathway analysis and can be applied for 
  




filtering out enzyme-encoding genes from the microarray platform. The relevant 
information was also utilized to construct the pathway network to demonstrate the 
interesting alterations of biological homeostasis under various scenarios at the 
hierarchy of metabolic pathway network (for details, please refer to section 3.6). 
 
3.2 Definition of metabolic gene category based on KEGG database 
 
The classification of metabolic genes into corresponding metabolic categories is based 
on KEGG database [167]. There are 11 main metabolic categories in the KEGG 
database: 1. Carbohydrate metabolism; 2. Energy metabolism; 3. Lipid metabolism; 4. 
Nucleotide metabolism; 5. Amino acid metabolism; 6 Metabolism of other amino 
acids; 7. Glycan biosynthesis and metabolism; 8. Metabolism of cofactors and 
vitamins; 9. Metabolism of terpenoids and polyketides; 10. Biosynthesis of other 
secondary metabolites; 11. Xenobiotics biodegradation and metabolism. Each main 
category is subdivided into several subcategories. This information was used for 
further pathway and network analysis. 
 
3.3 Hierarchical clustering 
 
In order to extract information from the pool of microarray data, an efficient way is to 
organize gene with similar patterns of expression into groups. Genes with similar 
patterns of expression under a set of experimental conditions are assumed to be 
  




regulated via a common molecular mechanism. Therefore, clustering the co-regulated 
genes is useful to identify common regulatory mechanisms and similar functional 
characteristics of those genes. Hierarchical clustering is one of the tools used to group 
data objects according to their pairwise similarity and widely used to identify the co-
expressed genes [170].  
 
3.3.1 Clustering algorithm 
Clustering algorithm groups together genes with similar expression profiles and 
separates genes with dissimilar expression profiles. The degree of similarity between 
the expression profiles is defined numerically by real-valued pairwise similarity 
function. Subsequently, the relations between genes will be represented by a tree that 
the branch length reflects the degree of similarity. There are several widely used 
pairwise similarity functions, among which we applied both the Pearson correlation 
(linear) and Spearman rank correlation (non-linear) functions to assess the similarity 
of gene expression profiles. 
 
1. Pairwise similarity measurement based on the Pearson correlation 
The most commonly used similarity function is Pearson correlation. Let  1, , nx x  
and  1, , ny y  be the expression profiles of gene x  and gene y  representative 
across the n  experiments, the Pearson correlation coefficient between these two series 
of numbers is defined as 
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where x  is the average of series  1, , nx x , x  is its standard deviation; y  is the 
average of series  1, , ny y , y  is its standard deviation. The Pearson correlation 
coefficient is between -1 and 1, with 1 meaning that two series are perfect linear 
correlated (positive), 0 meaning they are uncorrelated, and -1 meaning they are 
perfect negatively correlated. 
 
2. Pairwise similarity measurement based on the Spearman rank correlation 
The Spearman rank correlation calculates the association between the rank numbers 
of the data values in the two series. It assesses how well the relationship between two 
series can be described using a monotonic function. Thus, it can detect two series with 
non-linear correlation. If we convert the two data series  1, , nx x  and  1, , ny y  to 
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For example, if we have two data series  2.7,8.1,5.6,18.8x  ,  3.9,6.8,5.3,4.5y  , 
the first step is to replace two series by the rank numbers:  1,3,2,4x  , 
  




 1,4,3,2y  . Then the Spearman rank correlation can be calculated by above 
formula, resulting in 0.4  . In comparison, the Pearson correlation coefficient 
between two data series is 0.0193r   . By replacing the data values by rank numbers, 
the impact of the outlier 20.8 on the correlation coefficient can be reduced. Therefore, 
Spearman rank correlation is more robust against outliers. 
 
The first step in hierarchical clustering is to calculate the distance matrix between the 
gene expression profiles by using pairwise similarity function, such as Pearson 
correlation and Spearman rank correlation. The distance matrix is scanned to identify 
the highest value (representing gene pairs with most similar expression profiles) and a 
node is created joining these two genes. Note that once clustering commences, there 
will be two kinds of nodes: the true nodes (e.g. a single gene) and pseudo-nodes 
(contain a number of true nodes and pseudo-nodes). There are several ways to 
compute distances between pseudo-nodes, 
 
1. Single linkage: distance between two nodes is given by the minimal pairwise 
distance of the members of the first and second node. 
 
,
( , ) min ( , )
a A b B
D A B d a b
 
  
2. Complete linkage: distance between two nodes is given by the maximal pairwise 
distance of the members of the first and second node. 
 
,
( , ) max ( , )
a A b B








3. Average linkage: distance between two nodes is given by the pairwise distance of 
the arithmetic means of the members between first and second node. 
1 1
1
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i j i j
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Then the new distance matrix is calculated applying above linkage functions to the all 
nodes (including true nodes and pseudo-node) generated from last step. Nodes with 
highest value in the matrix are joining to a new node, and the distances to all other 
nodes are recomputed. The process is repeated until only one node remains. 
 
3.3.2 Hierarchical clustering software and setup 
The software ‘Cluster’ [171] (http://www.eisenlab.org/eisen/?page_id=42) was used 
for hierarchical clustering analysis of transcript profiles of zebrafish metabolic genes. 
Spearman Rank Correlation and Pearson Correlation were applied to calculate 
similarity matrix; average linkage was applied as clustering method. The tree image 
of profiles clustering is generated by the software ‘TreeView’ 
(http://www.eisenlab.org/eisen/?page_id=42). 
 
3.4 Sex-dependent expression score (SDES) 
 
In order to identify metabolic genes that display sex-dimorphic activities induced by 
different chemicals, the sex-dependent expression score (SDES) was devised to 
  




evaluate the magnitude of gene response acting in opposite direction in male and 
female fish under different chemical perturbations. The principle is based on assessing 
the compactness of individual gene transcriptional activities under different chemical 
treatments within one sex group versus the isolations between two sex groups. The 
basic concept of SDES is demonstrated in Figure 4. 
 
Grouping expression data  1, , ne e  of igene  under n  conditions into male group 
and female group  ,m fN N , where mN  and fN  denotes the set of conditions 
involving male and female respectively, the sex-dependent expression score (SDES) 















where ( )jSI e  is the Silhouette index of je , mN  and fN  denotes the size of the two 
sets. Assuming je  belongs to male group, then the Silhouette index of je  contains two 
elements: (i) compactness ja  which describes the average distance of je  to all other 
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Silhouette index of je , ( )jSI e , ranges from +1 to -1. Negative values indicate that 
this data should belong to a different cluster rather than the computed one. Therefore, 
the score of igene  ranges from +1 to -1, and a higher score indicates significant sex-
dependent activities of igene  under diverse chemical treatments. The FORTRAN 
















Figure 4. Principle of sex-dependent expression score (SDES).  
The design principle of sex-dependent expression score (SDES) is to evaluate the 
magnitude of gene response acting in opposite directions in male and female fish. A 
red box represents up-regulation and a green box represents down-regulation. (A) 
Gene1 has similar expression trend within male group (up-regulation) and female 
group (down-regulation) respectively, but, dissimilar between two sexes. In this 
situation, a high SDES value is assigned to gene1. (B) There is no pattern of sex-









3.5 Enrichment analysis tools 
 
The traditional way of gene expression analysis is to identify individual gene with 
significantly differential expression between two samples of interest. The single gene 
analysis technique can be very useful, for example, in screening for potential tumor 
markers or drug targets. However, single gene analysis may miss important biological 
information since the cellular process often affects a set of genes at the same time 
rather than individual gene. The synchronous increase or decrease of the expression of 
many genes in one biological pathway might impose greater impact on alteration of 
cellular homeostasis than the dramatically changed expression of one single gene. 
Thus, a holistic approach is required to analyze the transcriptomic data which focuses 
on interpreting order in the entire set of observations. 
 
3.5.1 Gene set enrichment analysis (GSEA) 
Gene set enrichment analysis (GSEA) [172] is a computational method that 
determines whether a pre-defined gene set (e.g., genes involving in specific metabolic 
pathway, located in the same cellular compartment, or sharing the same GO category) 
is overrepresented at the top or bottom of a ranked gene list. An enrichment score (ES) 
for each pre-defined gene set is calculated by walking down the ranked gene list, 
increasing a running-sum statistic when a gene in a pre-defined gene set is 
encountered ( ( , )presentP S i ) and decreasing it when the gene is absent ( ( , )absentP S i ). The 
ES is the maximum deviation of (  ( , ) ,present absentP S i P S i ) from zero encountered in 
the random walk corresponds to a weighted Kolmogorov-Smirnov-like statistic [173].  
  




































 ( ) max deviation from zero of ( , ) ( , )present absentES S P S i P S i     
 
where N is the total number of genes, SN is the number of genes belonging to gene set
S ,
jr is the correlation between the expression of gene j with the gene expression 
profile. Figure 5 demonstrates the working-principle of GSEA and the analysis 
details of two metabolic pathways from Chapter 4. 
 
The statistical significance of a given ES was estimated by using permutation test 
procedure. The ES of the gene set for the permuted data is recomputed to generate a 
null distribution for the ES. The empirical, nominal p-value of the observed ES was 
then calculated in relative to this null distribution. The ES for each gene set was then 
normalized to the size of the set, in order to eliminate the size effect, yielding a 
normalized enrichment score (NES) with the following relation: 
 
actual ES
mean ES calculated from all permutations of the dataset
NES   
 
 






Figure 5. Illustration of gene set enrichment analysis (GSEA).  
The running sum of pathway is represented by the green polyline and numerically indicated by enrichment score (ES). The genes are ranked in 
descending order according to the association between gene and interested phenotype (the color bar in the middle of figure; red: high association; 
blue: low association). (A) Genes belong to metabolic pathway “biosynthesis of unsaturated fatty acids” are significantly enriched for the 
interested phenotype (high enrichment score). (B) Genes are randomly distributed on the ranked list (low enrichment score).  
 
 




3.5.2 Gene set enrichment analysis (GSEA) software and setup 
The “GSEAPreranked” option of GSEA [172] software was used for gene set 
enrichment analysis. The input file of option “Ranked List” is the ranked list of genes 
in descending order based on value of sex-dependent expression score (SDES) for 
genes under chemical treatment and p-value (Student’s t-test) for genes in control 
group. The input file of “Gene sets database” is pre-defined metabolic pathways and 
corresponding genes generated from KEGG database [167]. The “Number of 
permutations” is set to 10000. Gene sets with less than 5 genes mapped to input were 
excluded from further analysis. 
 
3.5.3 Web-based gene set analysis toolkit (WebGestalt) 
Web-based gene set analysis toolkit (WebGestalt) [174] is an integrated data mining 
system for exploring gene sets in various biological contexts. The gene and gene 
product information in WebGestalt is taken from databases, such as Entrez Gene 
(http://www.ncbi.nlm.nih.gov/gene), Ensembl (http://www.ensembl.org/index.html), 
and KEGG [167] etc. In order to identify functional categories enriched with genes of 
interest, the genes of interest is compared with pre-defined reference gene set. 
 
Assuming there are n genes in the interesting gene set, and m genes in the reference 
gene set. In order to determine whether a given functional category is enriched or not, 
the number of genes belonging in to this given functional category is calculated, and 
assuming there are i genes and j  genes in the interesting gene set and reference gene 
set respectively. Therefore, the expected number of genes in this given category is, 
 
 








   
If i exceeds  E i , the given category is enriched in the interesting gene set. The 

















3.5.4 Pathway enrichment for the zebrafish sex-biased genes using WebGestalt 
Pathway enrichment for the zebrafish sex-biased genes was performed using the 
WebGestalt [174] (http://bioinfo.vanderbilt.edu/webgestalt/). Gene symbols matched 
to human genes were used for enrichment analysis on KEGG pathway. 
Hypergeometric test was used as a statistical method for enrichment analysis. 
Bonferroni method was then used as multiple test adjustment method. Pathways 
showing adjusted p-value < 0.01 with minimum 2 genes in a pathway category were 
considered as statistical significant. 
 
3.6 Metabolic pathway network reconstruction and visualization 
 
3.6.1 Metabolic pathway network reconstruction 
In the metabolic pathway network, each pathway is represented as node. If the 
product of one pathway is used as the substrate of another pathway there will be a link 
 
 




connecting these two pathways. For each pathway, its related partners can be found 
from KEGG database [167] (ftp://ftp.genome.jp/pub/kegg/pathway/pathway). In this 
study, only those metabolic pathways involving in GSEA calculation were used for 
network construction. The constructed metabolic pathway network has 41 nodes and 
84 links. 
 
3.6.2 Network visualization by Cytoscape 
Cytoscape is a free software for integrating biological networks with high-throughput 
expression data and other molecular states which can be used for visualizing and 
analyzing biological network in more detail [175, 176]. In Cytoscape, nodes represent 
biological entities (genes, proteins, and pathways etc.) which are connected with 
edges representing pairwise interactions. The dynamic states on those biological 
entities and their interactions are represented by the attributes on nodes and edges. 
Therefore, it is able to set visual aspects of nodes and edges, such as shape, color and 
size, based on attribute values. This data-to-visual attribute mapping allows biologists 
to synoptically view multiple types of data in a network context. 
 
In this study, Cytoscape is used to draw the metabolic pathway network combining 
with the states of sex-dimorphic response of each pathway at different chemical 
treatment stages which could investigate the coordination of the observed sexual 
dimorphism changes at network level (for detailed analysis, please refer to section 
4.2.6, Chapter 4). In addition, the integration of the biological states and network 
 
 




data is biologically relevant signals supported by both data types are more likely to be 
correct than those supported from either data source alone. 
 
 
Chapter 4 Chemical-induced sexual dimorphism in the 




The liver is the primary organ in mediating general metabolism and detoxification. A 
number of studies have shown that many hepatic genes associated with xenobiotic 
metabolism, such as cytochrome P450, are expressed in a sex-dimorphic manner 
during detoxification [62, 63, 144-146]. Apart from sex-dependent activities of genes 
related to xenobiotic metabolism, it is still unclear to what extent other forms of 
metabolic genes are differentially expressed in the two sexes in response to exogenous 
perturbations. 
 
In this work, our objective is to identify metabolic genes and pathways that display 
sex-dimorphic activities induced by different chemicals. Different chemicals can elicit 
specifically responsive genes which may be used as biomarkers. In addition to this, 
some studies also reported that diverse chemicals could disrupt normal cellular 
function through the same metabolic or signaling path. For example, in Ref. [177], the 
authors found that three chemically diverse toxicants, methylmercury, lead (heavy 
metal), and paraquat (organic herbicide), can activate the same regulatory pathway. In 
another article [114], the author also mentioned the fact that biomarkers are usually 
not specific to a particular contaminant, but instead, indicate a more general stress 
 
 




response. Therefore, exposing to toxicants with diverse chemical properties might 
trigger similar patterns of toxico-pathological responses. 
 
Here, the zebrafish was used as the model animal treated with four different 
environmental toxicants: 4-chloroaniline, 4-nitrophenol, arsenic (V), and cadmium 
(II). Sex-dimorphic expression of metabolic genes was examined by this author from 
the microarray data derived from these chemical-treated fish as obtained from my 
collaborators. Genes that show sex-dependent responses in the same direction across 
all chemical treatment groups (i.e. up-regulated in male but down-regulated in female 
or vice versa) are considered to be sex-dimorphic. The analysis showed that there 
were common sex-dependent responses of metabolic genes and pathways under these 
four chemical perturbations. The dynamics of the sex-dependent responses from 
individual genes, to pathways and pathway networks at the metabolic module level 
were also studied. Results in this work indicate the potential of using the zebrafish 
model to understand sex-dependent toxicology and pathology.  
 
4.2 Results and discussion 
 
4.2.1 Experimental outline and microarray analysis 
The overall experimental outline and microarray analysis are summarized in Figure 6. 
A total of 92 arrays for the chemical-treated groups (CA, 4-chloroaniline; NP, 4-
nitrophenol; As, arsenic (V); Cd, cadmium (II)) at four time points (8h, 24h, 48h, and 
 
 




96h) (duplicates for Cd female 8h, Cd female 96h, Cd male 8h, and Cd male 24h; 
others are triplicates) and 24 arrays (triplicates for both male and female at 8h, 24h, 
48h, and 96h) for the common control (untreated) groups were used. The full details 
of chemical concentrations, replicates, and the accession of the microarray data are 
given in Table 1. Annotated genes involve in a wide range of metabolism including 
xenobiotic metabolism are considered. Genes missing from microarray data under one 
or more chemical-treatment conditions were eliminated. Gene symbol for the 
zebrafish genes was obtained via mapping to human homologous genes and was 
subsequently used to map with metabolic genes defined in the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database [167]. A total of 307 metabolic genes were 
obtained under these selection criteria for further analysis (please refer to Figure 7 for 
demonstration). The gene symbols of 307 metabolic genes are given in Table 3 under 

















Figure 6. Flow chart of the overall experimental outline and microarray analysis.  
(A) The wet lab experiments were performed by collaborators from the Department of 
Biological Sciences. The detailed experimental protocols and processes can be found 
in Appendix A. (B) Fluorescent intensities of Cy-5 and Cy-3 dyes were recorded and 
raw data were normalized using Lowess method. Statistical test was performed for 
each treatment group followed by Z-score normalization for combined data for all 
treatments. Hierarchical clustering and correlation analyses for the identification of 
sex-dimorphic gene expression were conducted. Gene set enrichment analysis (GSEA) 










Figure 7. Demonstration of the matrix of metabolic gene response under 
chemical treatment conditions 
There are totally 307 metabolic genes selected under 32 chemical treatment 
conditions (2 sexes; 4 chemicals; 4 time points) 
 
Table 3. Gene symbols of 307 metabolic genes and their corresponding sex-
dependent expression score (SDES) under chemical treatment and p-value 
(Student’s t-test) under control (untreated) group 
Gene 
Symbol 
Sex-dependent expression score (SDES) 
 
p-value (Student’s t-test) 
8h 24h 48h 96h 8h 24h 48h 96h 
aanat2 0.131051 0.116345 -3.66E-02 -3.23E-02 0.247051 0.043119 0.492835 0.348555 
acadl 6.73E-02 -6.36E-02 0.432857 0.435206 0.11259 0.010054 0.694063 0.354873 
acadm -0.12635 0.486636 -2.60E-02 -0.12523 0.025576 0.002206 0.026863 0.04521 
acads 0.219772 -0.14956 0.200202 0.236048 0.272127 0.998158 0.076527 0.367906 
acadvl 0.116122 0.392774 0.584254 0.469413 0.314582 0.019965 0.855795 0.094891 
acat1 0.374496 -0.10023 -5.25E-02 0.183404 0.082863 0.028302 0.00048 0.011904 
acat2 -6.38E-02 -5.95E-02 -0.13974 -0.16968 0.885032 0.330267 0.995283 0.814667 
aco1 -3.88E-02 0.33898 7.64E-02 -1.14E-02 0.789655 0.123031 0.487621 0.937957 
acox1 0.401153 0.217573 0.127403 0.162774 0.028759 0.027006 0.062648 0.382667 
acox3 6.58E-03 6.87E-02 0.798245 0.455811 0.10108 0.233594 0.26514 0.856519 
acsl1 -7.91E-02 0.376782 0.474291 -0.1071 0.573839 0.016715 0.048805 0.049873 
acsl4 0.567633 2.03E-02 9.39E-02 0.466209 0.638584 0.238537 0.578064 0.207252 
acss2 -7.76E-02 0.661368 0.426022 -0.15932 0.63205 0.572497 0.435219 0.825207 
adh5 0.270882 1.74E-02 0.350398 -0.1119 0.217709 0.377749 0.015802 0.426163 
adka 0.287033 0.691425 0.198693 0.242738 0.035596 0.009052 0.007118 0.043219 
adkb 0.429721 -7.50E-02 5.60E-02 0.132256 0.024816 0.162078 0.257383 0.085344 
adob 0.437348 0.66752 0.501308 0.256588 0.011507 0.000104 0.001195 0.146018 
agk -7.88E-02 -0.12579 0.456519 2.86E-02 0.266722 0.024891 3.23E-05 0.00106 
agpat4 -0.11835 0.105257 7.30E-02 0.316957 0.037844 0.233574 0.004907 0.491356 
agpat9 0.106432 0.726196 0.279779 0.471461 0.311435 0.26533 0.335377 0.097857 
 
 




agxtl -0.15865 0.18748 0.201177 -0.13728 0.758694 0.342009 0.356001 0.134486 
ahcy 7.35E-02 9.81E-02 8.20E-02 0.4381 0.566243 0.462136 0.995223 0.760172 
ak2 0.432216 9.72E-02 0.541429 1.14E-04 0.062231 0.252378 0.004507 0.732346 
akr1a1b 0.287644 -3.70E-02 5.76E-03 -0.12867 0.232079 0.561413 0.941426 0.177896 
alas2 0.173862 -5.72E-02 5.24E-02 -2.15E-03 0.241348 0.362585 0.671235 0.468013 
aldh18a1 3.08E-02 0.185334 0.207125 4.61E-02 0.054258 0.11147 0.026245 0.154403 
aldh3a2 -3.66E-02 -5.15E-02 -4.15E-02 0.274469 0.566366 0.055907 0.317262 0.025734 
aldh4a1 0.124898 0.455016 0.51438 0.452541 0.462356 0.263318 0.070288 0.92802 
aldh7a1 6.09E-02 0.396079 9.77E-02 0.522098 0.922603 0.036862 0.915424 0.492393 
aldh9a1b 0.146892 -0.10223 -2.45E-02 -6.35E-02 0.237358 0.048759 0.054624 0.748564 
aldoaa 0.261265 0.13928 -0.13223 5.05E-02 0.233098 0.234697 0.03332 0.010128 
aldoab 0.153996 0.346826 5.14E-02 5.59E-02 0.47461 0.536824 0.000197 0.198335 
alg1 6.65E-02 -0.179 -5.40E-02 0.286884 0.966138 0.199826 0.094535 0.801321 
alg2 0.1261 -0.15256 1.32E-02 0.425047 0.613941 0.06048 0.004126 0.037691 
alg3 0.224637 0.2392 0.325947 -0.12521 0.935566 0.116882 0.333629 0.91593 
alg6 -0.13461 0.570143 0.147375 0.573194 0.115457 0.138826 0.094645 0.157069 
alg9 -5.60E-02 -0.10588 7.76E-02 0.246679 0.883083 0.545731 0.630467 0.551892 
amd1 0.459136 -0.11591 0.191173 0.43739 0.294783 0.279432 0.300583 0.141054 
ampd3 -0.16981 0.262742 0.219659 0.171109 0.947288 0.016094 0.045021 0.073474 
amy2a 0.633847 0.581472 2.89E-02 0.213987 0.04571 0.271736 0.500442 0.002023 
arg2 1.71E-02 2.78E-02 0.389564 -5.70E-02 0.418155 0.191553 0.003485 0.004088 
ash1l 0.411343 0.509242 0.384771 -4.69E-02 0.374595 0.15645 0.075215 0.494461 
ass1 0.356468 0.236279 0.153109 0.518115 0.578715 0.552437 0.441486 0.948452 
atic 0.393636 -0.11499 -0.10722 0.180314 0.154951 0.005838 0.019326 0.210589 
atp5a1 -4.37E-02 0.198972 0.414905 0.122603 0.374077 0.002223 0.000854 0.499859 
atp5c1 -2.47E-02 -0.19276 -0.18582 9.49E-02 0.159972 0.248398 0.057749 0.067606 
atp5f1 -8.18E-02 0.207708 -0.15128 0.349098 0.010977 0.078823 0.267416 0.002824 
atp5g 0.398469 -7.28E-02 -0.12375 0.293618 0.374045 0.008012 0.470386 0.968647 
atp5i 0.410023 0.258746 -0.15952 -0.12178 0.575202 0.18232 0.139045 0.772772 
atp5l -6.13E-02 7.40E-03 -4.41E-02 -0.16397 0.50443 0.622522 0.361056 0.210711 
atp5o 0.288152 0.250282 -3.01E-02 -4.87E-02 0.630262 0.304542 0.559377 0.083675 
atp6v0d1 -7.00E-02 0.279743 0.146511 4.41E-02 0.986567 0.496465 0.69595 0.175903 
atp6v1ba -0.14779 0.230584 0.463066 -4.77E-02 0.487717 0.147006 0.265235 0.447922 
atp6v1e1 -8.28E-02 -6.14E-02 0.147427 -8.90E-02 0.81561 0.798456 0.966618 0.099972 
atp6v1f 3.81E-02 0.213735 5.70E-02 0.138357 0.53295 0.032462 0.204138 0.094464 
atp6v1g1 4.63E-02 0.276566 9.31E-02 0.344608 0.351897 0.001826 0.01668 0.125362 
atp6v1h -0.12599 -0.14269 -2.67E-02 0.109619 0.964788 0.243428 0.655407 0.744579 
auh -2.41E-03 0.268421 -0.10466 9.48E-02 0.136263 0.037533 0.948578 0.263406 
bcat1 0.161294 1.77E-02 0.164672 1.19E-02 0.121425 0.133447 0.117459 0.095331 
bcat2 -6.82E-02 0.251272 4.06E-02 0.460821 0.05347 0.793411 0.052708 0.711576 
bckdha -7.50E-02 0.104199 0.244531 4.33E-03 0.264613 0.009078 0.753517 0.415727 
bcmo1 0.117226 0.199699 -2.79E-02 0.324401 0.458379 0.774674 0.342986 0.041746 
cad -3.93E-02 0.142449 0.113649 -0.11311 0.070887 0.171158 0.073061 0.951602 
cahz 0.117644 3.45E-02 0.127131 -0.13374 0.186512 0.288749 0.407568 0.060933 
cat 7.00E-02 0.120985 0.285847 6.71E-02 0.233552 0.357757 0.244149 0.628043 
cbs -0.16168 -0.11812 -0.16536 -3.12E-03 0.300572 0.013673 0.08516 0.003347 
ccbl2 0.1506 4.18E-02 -6.94E-02 -0.1276 0.123141 0.009191 0.457722 0.579753 
chpt1 0.167404 0.546033 0.185496 0.188626 0.017342 0.014882 0.016377 0.316004 
ckma -3.56E-02 0.37411 0.109579 -0.15113 0.164466 0.360428 0.25327 0.58042 
ckmt1 -6.36E-02 0.105976 -9.27E-02 0.354557 0.664811 0.317115 0.669664 0.425924 
cmas -0.12665 -5.98E-02 0.452963 0.583591 0.770481 0.009148 0.030632 0.112848 
 
 




cmpk 9.28E-03 5.36E-02 -1.14E-02 0.258667 0.246978 0.309133 0.088998 0.04581 
cox4i1 -0.16622 0.193408 3.75E-02 6.06E-02 0.719123 0.055975 0.584021 0.090074 
cox5aa 0.135349 -0.12312 4.20E-02 -9.26E-02 0.432742 0.28197 0.465894 0.05083 
cox5ab 0.226399 -0.1692 -9.32E-02 -3.21E-02 0.4174 0.222377 0.115657 0.180485 
cox6a1 0.26046 0.465613 -9.73E-02 7.17E-02 0.788198 0.092431 0.758529 0.006769 
cox7a2 0.15226 -0.14496 -0.13138 6.49E-03 0.571166 0.756325 0.948065 0.284723 
cox7a2l 9.35E-02 0.645632 0.189538 0.243781 0.67789 0.004331 0.07349 0.680547 
cox7c 6.18E-02 -3.56E-03 0.126337 -0.17804 0.993015 0.026166 0.127036 0.212497 
cp -1.12E-02 0.30752 0.25061 0.30335 0.477662 0.011237 0.127383 0.402683 
cpla2 6.95E-02 1.27E-02 -0.12581 0.214339 0.595516 0.004601 0.594635 0.900296 
cpt2 -4.97E-03 0.252141 0.736657 0.129979 0.009143 0.011822 0.004232 0.27542 
csad -1.05E-02 0.689158 0.592973 0.689921 0.629878 0.119985 0.02602 0.029471 
cth -8.84E-03 0.111071 -9.59E-02 -3.99E-02 0.158948 0.508748 0.016722 0.011423 
ctps 5.34E-02 2.12E-03 0.623672 0.48515 0.677419 0.84169 0.504684 0.416102 
cyc1 0.190712 0.517948 -0.15185 0.101778 0.065007 0.045914 0.001736 0.134484 
cyp1a 6.79E-02 0.414325 5.90E-02 0.10218 0.003969 0.004738 0.000365 0.036795 
cyp2j22 1.74E-02 -0.20808 0.196947 5.82E-02 0.908314 0.788437 0.177164 0.911233 
cyp51 0.385955 0.179689 -0.14513 -4.05E-02 0.357804 0.336131 0.307279 0.244254 
d4st1 0.244482 -0.14393 -9.57E-02 4.51E-02 0.953859 0.745005 0.07252 0.222874 
dad1 0.124556 -0.20652 1.71E-02 0.352974 0.214239 0.679121 0.244411 0.04797 
dbh 1.61E-02 -1.69E-02 -6.90E-03 0.171389 0.075219 0.312145 0.769104 0.003465 
dct 0.277714 0.399834 2.26E-02 0.19466 0.312672 0.00547 0.423437 0.909695 
dcxr 5.53E-02 0.145862 0.231832 -4.01E-02 0.878292 0.612723 0.764906 0.624837 
degs1 0.232493 -3.90E-02 0.282661 8.80E-02 0.230329 0.405835 0.276272 0.058104 
dgat1 0.184822 5.35E-02 0.16161 0.284374 0.558471 0.719007 0.048248 0.00302 
dhcr7 -0.11242 -7.59E-02 -2.10E-02 0.183153 0.50821 0.895659 0.724416 0.590076 
dhdds 0.265624 0.549581 -6.99E-02 0.606382 0.735799 0.104474 0.266407 0.148209 
dhdhl -0.21201 7.62E-02 -0.10778 0.11998 0.195141 0.636933 0.164212 0.193079 
dhfr -0.11624 6.48E-02 0.27038 8.81E-02 0.320146 0.119225 0.306017 0.075008 
dlat 7.91E-02 0.233633 4.09E-02 -0.13453 0.413795 0.2636 0.079932 0.756673 
dnmt1 -9.18E-03 -6.15E-02 -4.57E-02 -9.81E-02 0.156511 0.399265 0.092803 0.48921 
dnmt5 3.10E-02 2.77E-02 -5.83E-02 -0.10187 0.263329 0.076863 0.373983 0.445624 
dnmt7 0.374813 6.85E-02 -6.96E-02 0.441425 0.791048 0.950652 0.604639 0.067796 
dpm1 -8.07E-02 4.24E-02 0.287219 0.162257 0.046095 0.072858 0.00351 0.06275 
dpyd 1.85E-02 0.484259 0.179742 -4.46E-03 0.510355 0.345724 0.176952 0.020442 
echs1 8.82E-03 0.239237 0.409181 -9.21E-02 0.253581 0.013908 0.043998 0.00145 
ehmt1a 0.515943 0.122621 0.1346 0.490691 0.077117 0.026026 0.440271 0.129045 
elovl5 0.596164 5.06E-02 0.548303 0.295682 0.014118 0.018557 0.039809 0.378145 
elovl6 -1.22E-02 0.673848 0.738464 0.246808 0.352077 0.200051 0.109547 0.705795 
eno1 0.165663 -6.91E-02 1.10E-02 0.473726 0.122452 0.57841 0.682382 0.046298 
eno2 8.52E-02 0.187738 -8.01E-03 -0.14242 0.349947 0.453352 0.130433 0.139448 
enpp6 0.178048 0.239971 0.160292 0.337499 0.589846 0.698092 0.436066 0.002687 
ephx1 -6.68E-02 0.230327 1.19E-02 0.411527 0.056256 0.310661 0.134253 0.325591 
ext1a -0.11835 -5.93E-02 0.713506 0.331095 0.102212 0.644121 0.049556 0.006029 
extl3 0.174731 0.433753 0.553488 0.464292 0.904419 0.57186 0.149704 0.005176 
fads2 -7.75E-03 0.342036 0.342592 -2.39E-02 0.016944 0.0721 0.003377 0.010769 
fdps 0.221647 0.103763 0.25758 -0.1311 0.384591 0.981161 0.737371 0.068591 
fech 0.102286 0.306176 -6.82E-02 0.313358 0.020518 0.012723 0.110107 0.950902 
fhit 5.24E-02 0.175877 0.314835 0.120582 0.931162 0.041465 0.579387 0.211704 
fmo5 4.48E-02 0.278226 0.673001 0.343056 0.57595 0.375405 0.069823 0.713444 
fpgs 0.213468 0.127355 7.38E-02 0.526948 0.045824 0.241327 0.009222 0.013442 
 
 




fth1 8.21E-02 -0.16519 -5.53E-02 -8.75E-02 0.825009 0.672004 0.072368 0.088698 
fuca1 0.21865 0.163208 0.232104 -6.67E-02 0.484687 0.452568 0.738209 0.289098 
gale -0.16976 -2.96E-02 0.733262 0.127178 0.072793 0.921333 0.002454 0.133362 
gapdh -7.94E-02 -0.19496 6.10E-02 -1.33E-02 0.077334 0.078426 0.412291 0.596723 
gart -1.47E-02 -7.13E-02 0.303031 -2.34E-02 0.45432 0.420518 0.136148 0.648868 
gatm 0.128238 7.08E-02 -0.17024 9.07E-03 0.260379 0.21217 0.054057 0.001852 
gcat -8.78E-02 0.735363 -3.04E-02 -0.1083 0.063883 0.30677 0.022171 0.102364 
gcdh -0.18253 -0.1513 0.135503 -7.08E-02 0.548911 0.574532 0.197954 0.004871 
gclc -0.11112 0.136402 0.146594 0.645593 0.002763 0.50728 0.173592 0.721288 
gclm -7.64E-02 -8.25E-02 -1.18E-03 0.224663 0.467399 0.109699 0.167579 0.223924 
gcnt4 -2.81E-02 0.318163 6.32E-02 0.124045 0.737896 0.151799 0.410412 0.01496 
gldc 9.48E-03 0.390974 0.263517 0.311299 0.040427 0.268976 0.003123 0.042848 
glo1 -0.18455 2.72E-02 -2.77E-02 0.544311 0.551498 0.493267 0.326078 0.688741 
glud1b 0.256733 0.177468 -6.43E-02 -4.68E-02 0.191117 0.544008 0.61136 0.048142 
gmds 0.241843 0.201928 0.118571 1.45E-02 0.596982 0.01974 0.538099 0.920635 
gmps -0.19434 0.411285 -0.14422 0.177602 0.738858 0.003103 0.520605 0.121775 
gne -0.14849 0.754898 0.670221 -9.81E-02 0.003983 0.002572 0.020371 0.197134 
got1 0.12408 0.390716 -0.12495 0.220789 0.069939 0.62451 0.885194 0.609162 
got2b 0.15859 0.204856 -3.21E-02 0.113325 0.851351 0.060601 0.179699 0.10328 
gpd1 0.138514 5.69E-02 0.366779 -1.13E-02 0.326909 0.831279 0.334108 0.166277 
gpd1l -8.36E-02 5.37E-02 0.380966 0.181858 0.380129 0.391894 0.002798 0.815095 
gpia 0.200804 0.42178 0.274039 -8.03E-02 0.094196 0.573419 0.053693 0.280237 
gpt2 -2.82E-02 3.60E-02 0.286116 0.712944 0.492104 0.040383 0.001748 0.002039 
gpx1a -0.16023 -0.15892 7.01E-02 0.257794 0.340584 0.194048 0.467175 0.404928 
gpx4b -0.13691 -0.20945 7.33E-02 -9.26E-02 0.646344 0.314828 0.164271 0.116168 
gstal 0.228916 -0.14228 0.314315 0.530408 0.046659 0.740381 0.841287 0.183116 
gstp1 -0.15197 -5.67E-02 -0.15541 -0.17129 0.453798 0.003417 0.205528 0.009779 
gucy2f 0.234592 0.312944 0.527625 0.517539 0.154374 0.150166 0.061074 0.169601 
hadh 5.68E-02 -9.07E-02 0.375872 -0.1934 0.753321 0.452574 0.232101 0.106772 
hadhb 0.399341 8.62E-02 0.316022 0.156343 0.636522 0.002633 0.592923 0.225423 
hagh 0.258954 2.81E-02 8.62E-02 0.24289 0.004072 0.017512 0.007717 0.359361 
hao1 -4.79E-03 -7.02E-02 0.52205 0.39155 0.725995 0.673205 0.291828 0.362689 
hccs 8.76E-02 0.216538 -0.19055 0.315857 0.004743 0.399865 0.893661 0.003099 
hccsa -3.36E-02 6.57E-02 -2.77E-02 0.140249 0.478496 0.402092 0.365023 0.394364 
hgd 0.139046 -0.1182 -0.14075 6.94E-02 0.658519 0.619894 0.394153 0.875477 
hibadhb -2.22E-02 8.32E-02 0.217331 -9.15E-02 0.736063 0.604493 0.037629 0.320646 
hk1 -5.00E-02 3.35E-02 -0.15929 4.84E-02 0.623731 0.104503 0.509746 0.154829 
hk2 -0.13162 -4.08E-02 4.80E-02 0.340399 0.171546 0.29229 0.667291 0.029781 
hmbsa 0.226073 0.442681 0.273329 0.41307 0.18968 0.504986 0.921389 0.081807 
hmgcl 0.662587 0.489055 0.296693 -3.13E-02 0.128468 0.086388 0.035847 0.336451 
hmgcs1 0.350305 0.381094 2.59E-02 -0.19332 0.417511 0.011677 0.118629 0.264657 
hmox1 0.364759 -5.56E-02 -0.14404 0.183582 0.278026 0.037576 0.01937 0.000136 
hprt1 0.233287 7.70E-02 -0.124 0.111735 0.458596 0.487574 0.275218 0.309285 
hs6st1a -0.11698 0.44069 -5.11E-02 0.167249 0.353667 0.023143 0.457331 0.099984 
hs6st2 -2.22E-02 -8.16E-02 0.674829 0.409222 0.153169 0.019856 0.272139 0.873427 
hsd11b2 -8.33E-02 0.560509 0.340817 0.171928 0.075877 0.296707 0.039717 0.229645 
hsd17b10 8.51E-02 -0.13775 -9.27E-02 0.266363 0.35551 0.059274 0.100898 0.179297 
hsd17b4 -6.81E-02 -0.1997 0.591976 0.659439 0.520121 0.090703 0.012102 0.223394 
hsd17b8 8.80E-02 -1.97E-02 -6.77E-02 0.614278 0.338817 0.11027 0.586618 0.577108 
hsd3b7 0.266293 -8.75E-03 0.475605 0.655938 0.809629 0.166859 0.116206 0.642962 
iars -0.1356 0.704659 0.741068 4.72E-02 0.115305 0.005584 0.003396 0.044421 
 
 




idh2 -3.08E-02 -4.12E-02 -1.84E-02 0.528063 0.405953 0.532573 0.23751 0.801318 
impa1 0.31701 0.423975 6.75E-02 0.102244 0.014427 0.016035 0.646851 0.478189 
impdh2 0.177942 0.42607 0.334041 0.713206 0.271088 0.010627 0.003536 0.116984 
itm1 0.544042 0.42209 0.397408 -0.11382 0.041532 0.01671 0.008461 0.547248 
ivd -6.07E-02 5.07E-04 -6.50E-02 0.148069 0.948647 0.685824 0.431485 0.146335 
kmo 8.66E-04 -2.17E-02 -5.55E-02 0.489131 0.085858 0.081101 0.241283 0.238921 
lap3 0.162828 0.203695 0.125945 6.55E-03 0.429657 0.502279 0.283729 0.844726 
lars 0.305291 0.191256 0.381216 0.575452 0.199909 0.157863 0.109172 0.128335 
ldha 0.110491 7.17E-02 4.55E-02 -5.99E-02 0.159547 0.772214 0.015278 0.043987 
ldhb 5.19E-02 -5.12E-02 0.251948 0.42329 0.543171 0.000641 0.802198 0.020166 
ldhd 0.338601 0.107908 0.351874 3.87E-02 0.863074 0.859539 0.217568 0.191222 
lipf 0.199769 0.166621 -0.20887 5.86E-02 0.634734 0.971392 0.244575 0.098574 
lpl -8.67E-02 -0.13838 -0.16277 -5.20E-02 0.758127 0.44998 0.771892 0.100703 
lta4h -4.10E-02 9.93E-02 0.159658 0.518934 0.018208 0.33271 0.726793 0.052015 
mao -0.11565 0.421687 0.147051 -2.79E-02 0.010204 0.002682 0.005728 0.11114 
mdh1a 0.302534 8.66E-02 5.52E-02 0.349169 0.116239 0.925043 0.611138 0.269202 
me2 0.28348 0.739255 8.14E-02 -7.52E-02 0.728361 0.032634 0.368124 0.489267 
mgll -0.14278 -2.84E-02 0.609152 0.53357 0.159655 0.038791 0.151807 0.20869 
mif 0.390738 0.313555 -0.21794 5.67E-03 0.10771 0.109743 0.068863 0.48996 
mthfd1 3.56E-02 0.596627 0.466841 0.156452 0.021448 0.006525 0.274159 0.396445 
mtmr6 -1.03E-02 0.275949 -2.90E-02 -0.13671 0.228828 0.199602 0.299989 0.004131 
mtr -0.11899 0.240989 0.262691 -0.19007 0.012958 0.046249 0.001238 0.197684 
mut 0.176576 0.655666 0.356622 0.199423 0.061206 0.019131 0.001937 0.012243 
ndpkz2 -6.15E-02 0.211884 0.362328 0.438097 0.423304 0.002112 0.021949 0.002137 
ndpkz4 0.459841 0.574797 0.297731 0.387339 0.318691 0.091249 0.586317 0.033878 
ndufa10 0.158747 -8.88E-02 -4.89E-02 0.140602 0.923498 0.741653 0.338945 0.051688 
ndufa4l -0.20241 -2.68E-02 -0.11606 -3.18E-02 0.941773 0.925501 0.569623 0.330792 
ndufa6 -6.19E-02 -0.10317 0.366653 -4.07E-02 0.405126 0.214294 0.176018 0.452088 
ndufa9 -0.11041 0.308058 -0.17014 -4.26E-02 0.905293 0.051665 0.167427 0.120932 
ndufab1 0.231329 -2.85E-02 -5.18E-02 7.34E-02 0.821532 0.189869 0.354298 0.593739 
ndufb10 0.102033 -0.15101 3.98E-02 0.258721 0.293213 0.172872 0.172404 0.181009 
ndufb4 0.143763 0.146862 0.175377 0.221581 0.116563 0.736962 0.8831 0.322073 
ndufb5 0.322128 4.16E-02 0.188344 6.00E-02 0.151634 0.053429 0.401549 0.062452 
ndufb8 2.70E-02 7.10E-02 0.376746 -0.1237 0.009732 0.060763 0.405387 0.489079 
ndufs1 -0.14915 4.52E-02 4.62E-02 0.157247 0.455633 0.171228 0.915334 0.283637 
ndufs3 2.06E-02 0.182112 -1.94E-03 0.112779 0.807431 0.427437 0.172634 0.322583 
ndufs5 0.122851 -0.17291 0.24731 4.27E-02 0.574037 0.174936 0.102418 0.313799 
ndufs6 -1.08E-02 0.36867 -0.11072 0.124912 0.72242 0.334568 0.736893 0.030782 
ndufs8 -6.84E-02 -0.12627 -0.11822 2.00E-02 0.423426 0.959952 0.811737 0.175899 
nme2 -1.11E-02 0.26409 0.208804 0.144929 0.147203 0.00514 0.076241 0.325407 
npl 0.552713 -4.11E-02 0.289437 0.348964 0.369457 0.020415 0.002947 0.016692 
nsd1a 0.724667 0.258369 0.110004 -2.21E-02 0.042472 0.440085 0.164624 0.129498 
nt5c2 -9.44E-02 7.28E-02 0.391191 0.129871 0.461526 0.033523 0.070049 0.005506 
nudt5 -9.93E-02 0.387788 0.285936 0.63396 0.649053 0.0159 0.698934 0.000937 
nudt9 0.675781 0.514585 -4.21E-02 -0.16172 0.342729 0.069 0.38496 0.397708 
odc1 0.123272 5.74E-02 0.490018 0.154504 0.600411 0.017843 0.001494 0.127433 
ogdh 0.445184 0.165958 0.202122 0.256451 0.293823 0.103227 2.04E-05 0.018895 
pafah1b1b -5.95E-03 -0.12701 0.223405 -9.20E-02 0.065811 0.257427 0.233567 0.75655 
pafah1b3 3.33E-02 0.357256 0.424377 0.271737 0.933546 0.703044 0.172814 0.946049 
pah -4.71E-02 0.367489 0.20742 0.11404 0.733961 0.361597 0.160128 0.99321 
paics -3.72E-02 0.798931 -0.10665 -0.18715 0.39907 0.034992 0.923083 0.040764 
 
 




papss2 6.70E-02 3.67E-02 0.306196 4.11E-02 0.600525 0.18022 0.003339 0.026763 
pc 0.188553 0.42901 0.177152 7.30E-02 0.434246 0.007264 0.507367 0.080075 
pccb -0.12784 -8.35E-02 4.41E-02 0.778426 0.675733 0.951283 0.696454 0.070858 
pde6c 0.186012 0.169405 0.113556 8.18E-02 0.398047 0.296375 0.826741 0.815566 
pdss1 -0.21974 2.69E-02 0.169532 0.582844 0.515457 0.408097 0.308291 0.241363 
pfkfb2 -0.14074 0.257981 -0.14333 0.638906 0.402743 0.257989 0.262944 0.007094 
pfkfb3 -0.15666 0.306099 0.254857 1.30E-03 0.225059 0.021388 0.418437 0.439937 
pgd -3.37E-03 7.95E-02 0.372147 0.211865 0.264801 0.100048 0.044751 0.245744 
pgk1 0.350396 -8.41E-02 5.28E-02 0.299882 0.012187 0.073186 0.004924 0.226213 
pgls -8.51E-02 0.137369 0.278024 -6.40E-02 0.116291 0.077973 0.079042 0.260467 
pgm1 0.267182 -7.53E-02 0.742161 8.87E-02 0.131506 0.266357 0.005114 0.373173 
pi4kb 8.30E-02 0.340032 -0.16874 0.149925 0.052927 0.050455 0.115433 0.481356 
pigf -4.72E-02 0.181159 -0.17138 0.167478 0.564479 0.622961 0.937928 0.006675 
pigq 3.79E-02 0.11468 -5.88E-02 -0.16768 0.843331 0.718639 0.626165 0.662913 
pip5k2 0.699043 0.181502 0.780339 -0.17418 0.032746 0.038337 0.056414 0.494289 
pklr 0.52511 0.170902 0.642071 -3.30E-02 0.149614 0.407258 0.025021 0.094766 
pkm2a 0.104593 4.31E-02 -4.61E-02 0.451446 0.05454 0.670708 0.124069 0.017459 
pmm2 0.117922 0.231376 0.433903 -5.84E-02 0.224539 0.946219 0.352319 0.294395 
pnpo 7.89E-03 0.139365 0.282647 9.36E-02 0.222371 0.89233 0.047994 0.071668 
polr1a -7.45E-02 -0.17892 0.421861 6.74E-02 0.638734 0.040612 0.004106 0.076364 
polr1c -0.10927 5.44E-02 0.574185 0.60876 0.295119 0.363497 0.197444 0.28139 
polr2e -0.15738 0.221673 0.533079 0.514202 0.829098 0.351435 0.021101 0.025575 
polr2gl -9.83E-02 3.62E-02 -1.28E-02 -0.12876 0.486646 0.739027 0.640779 0.686314 
polr3b -9.25E-02 0.33808 0.424716 0.248467 0.472815 0.127538 0.474321 0.169318 
polr3k 0.356231 0.289653 0.501662 0.543283 0.07018 0.764931 0.115778 0.237911 
pomt2 -4.38E-02 -0.1059 -0.1153 0.848552 0.197676 0.449584 0.749682 0.064032 
ppt1 -3.21E-02 0.314063 0.540648 0.41214 0.503729 0.206604 0.566195 0.396626 
prdx6 -0.14092 2.96E-02 -0.11245 -8.92E-03 0.541273 0.028742 0.770606 0.476146 
prps1a -0.14834 -5.25E-02 -3.61E-02 5.82E-02 0.08167 0.422263 0.55133 0.0325 
psat1 3.01E-02 0.758071 0.506099 7.28E-02 0.666476 0.017199 0.512117 0.522586 
ptdss1 7.51E-02 0.823592 0.574053 4.91E-02 0.909844 0.460802 0.319328 0.478237 
ptenb 0.123485 8.81E-02 0.202735 -6.84E-02 0.133972 0.368824 0.010305 0.202982 
ptgds -0.16805 0.638927 0.641864 0.752186 0.587555 0.00025 0.000549 0.028066 
ptplb 0.279297 0.396933 0.296451 2.01E-02 0.266409 0.001145 0.015761 0.267982 
pygl 0.288297 0.241418 0.200808 0.397458 0.195601 0.397827 0.167657 0.376129 
rdh12 0.124167 -9.35E-03 3.41E-02 0.444438 0.965765 0.289842 0.913328 0.000175 
rdh8 -2.39E-02 0.664843 -0.13204 -2.96E-02 0.12126 0.520215 0.453909 0.520753 
retsat 3.21E-02 0.200066 0.344336 0.246753 0.511626 0.003416 0.414575 0.738088 
rpe -0.15756 -0.20021 0.116226 -0.1318 0.925224 0.829727 0.865764 0.650211 
rrm1 8.18E-02 4.08E-02 0.228186 0.254373 0.447041 0.222519 0.412767 0.115476 
rrm2 0.150384 0.585352 0.374334 0.126947 0.235 0.001328 0.384957 0.61129 
sc4mol 0.222598 -0.1334 -0.11132 -0.14415 0.341093 0.354788 0.017871 0.507651 
scd 0.297033 0.261032 0.53345 -0.15958 0.126221 0.009916 0.000226 0.094311 
scp2 0.191748 0.123975 -5.87E-02 -3.84E-02 0.43192 0.996121 0.57819 0.593853 
sdha -0.10572 4.41E-02 -6.79E-02 -1.35E-02 0.204597 0.044196 0.083383 0.757763 
sdhb 0.188303 0.129589 -0.1021 0.259687 0.189974 0.232487 0.240657 0.027155 
sdhc -0.1127 -8.00E-02 0.183245 -0.19234 0.47185 0.156222 0.009244 0.091537 
sdhda 0.13309 -0.13219 -3.89E-02 -6.20E-02 0.503178 0.210845 0.492501 0.054183 
sephs1 0.50499 0.102725 3.81E-03 0.224945 0.216004 0.694737 0.93757 0.034418 
setd8b -8.97E-02 0.146365 -4.76E-02 -6.17E-02 0.922141 0.165153 0.378691 0.266164 
setdb2 3.52E-02 -0.20872 0.275749 -0.15234 0.627367 0.090862 0.028446 0.133384 
 
 




setmar -4.90E-02 0.653296 7.50E-03 -0.13043 0.848999 0.003771 0.76603 0.210677 
shmt1 1.59E-03 0.483035 0.32587 -6.13E-02 0.067964 0.996606 0.560378 0.023394 
shmt2 2.62E-02 0.236698 0.619695 0.440453 0.163972 0.001593 0.002841 0.142619 
sms 0.101211 0.2029 0.105652 -9.31E-02 0.12604 0.240988 0.027409 0.157113 
sps2 -9.22E-02 -5.74E-02 4.49E-02 0.1912 0.520422 0.803286 0.192077 0.56848 
srd5a3 -7.96E-03 0.397501 -5.06E-02 2.74E-02 0.961303 0.020459 0.80031 0.245157 
st3gal5 -9.68E-02 0.315918 -4.86E-02 -0.17501 0.698163 0.395855 0.564835 0.366201 
st6gal2 -0.10097 0.241871 0.274143 -0.10818 0.1297 0.011614 0.837687 0.347169 
suclg2 0.163105 0.121531 0.188719 -1.25E-02 0.630514 0.776953 0.816872 0.091795 
suv39h1a -9.45E-02 -6.11E-03 0.543871 0.139016 0.542239 0.612088 0.108279 0.650062 
suv420h1 0.23845 -0.17959 -1.23E-02 6.45E-02 0.69529 0.872211 0.172775 0.594794 
taldo1 0.143201 0.43332 0.1844 0.198043 0.179143 0.002545 6.76E-05 0.001152 
tat -5.34E-04 -0.17466 -0.20953 -0.13722 0.894973 0.969069 0.41957 0.549723 
taz 4.07E-02 5.24E-02 0.306306 -1.87E-02 0.38703 0.392453 0.013437 0.936743 
tbxas1 3.63E-02 7.89E-02 0.221924 0.510475 0.167981 0.0853 0.06054 0.02356 
tdh 0.60945 0.141227 9.67E-04 -7.44E-02 0.587738 0.104083 0.902606 0.069443 
tph1a 0.724954 -1.21E-02 -0.12258 0.176289 0.21905 0.095568 0.556863 0.104789 
tpi1b -0.10799 0.323157 -0.1126 0.199457 0.084625 0.053245 0.034877 0.179646 
txnrd1 0.162934 3.35E-02 0.248945 1.52E-02 0.472657 0.014212 0.517805 0.045599 
uap1l1 -9.33E-03 4.43E-02 0.304873 -2.59E-02 0.908754 0.912802 0.187762 0.523407 
uck2b 0.224537 0.297864 -3.36E-02 0.575811 0.256123 0.263338 0.499505 0.072498 
ugdh 0.301983 -0.12377 0.462271 -0.11834 0.164264 0.229673 0.707362 0.654464 
ugt1ab 0.597469 7.42E-02 -0.1713 -3.84E-02 0.003931 0.100628 0.015615 0.156058 
upb1 0.318425 0.562414 0.408878 -1.59E-02 0.741146 0.026688 0.012266 0.261514 
uqcrb -6.66E-02 0.148874 5.42E-02 -2.36E-02 0.386278 0.253365 0.907813 0.115719 
uqcrfs1 0.306039 0.348579 -6.84E-02 0.557013 0.741055 0.470767 0.222001 0.019974 
uqcrq -9.68E-02 0.53911 9.28E-02 -0.12306 0.235164 9.02E-05 0.275756 0.07981 
urod 3.21E-02 0.459365 -4.40E-02 -4.25E-02 0.498067 0.263337 0.12658 0.472071 
uros -1.85E-04 0.162711 0.631428 -3.23E-02 0.43775 0.007848 0.046564 0.273441 
vars -4.15E-02 -9.32E-02 0.237777 -0.15124 0.175324 0.324568 0.981799 0.11641 
wars 0.655064 -3.18E-03 -0.14796 -8.87E-02 0.979861 0.604378 0.152488 0.483879 
wwox 0.151917 -0.1787 -5.37E-02 0.261054 0.621386 0.089473 0.21946 0.676535 
 
4.2.2 Hierarchical clustering of zebrafish liver metabolic transcript profiles 
suggests chemical-induced sex-dimorphic responses 
Unsupervised hierarchical clustering was applied to all datasets to generate a 
dendrogram (Figure 8). It is obvious that branches under each subtree belong to one 
sex, either male or female. Moreover, the branches of the dendrogram were generally 
organized according to different treatment times, indicating the progression of 
chemical-induced sex-dimorphic responses.  
 
 






Figure 8. Hierarchical clustering of zebrafish liver metabolic transcript profiles 
in response to chemical perturbations. 
Unsupervised hierarchical clustering (Spearman rank correlation) of the metabolic 
transcript profiles indicates sex-dependent metabolic gene expression in response to 
chemical treatment. Branches placed under subtrees only consist of one sex. In 
general, branches clustered under subtrees belong to the same stage of chemical 
treatment. 
 
This observation warranted a further interrogation about the dynamics of metabolic 
response with respect to increasing duration of chemical treatment. Consequently, the 
unsupervised hierarchical clustering (Spearman rank correlation) was applied to the 
eight metabolic transcript profiles (CA female & male, NP female & male, As female 
& male, Cd female & male) for each time point. At 8 hours of chemical treatment, 
with the exception of arsenic, transcript profiles of the three other chemical treatment 
groups were loosely clustered according to sex. The early impact of arsenic exposure 
on the metabolic gene expression appeared to surpass the effects of sex-dependency 
so that arsenic-treated males and females were clustered together. However, a clear 
 
 




sex-dependent clustering pattern was observed starting from 24 to 96 hours of 
chemical treatment (Figure 9A). Similar clustering results were also obtained using 
Pearson correlation (Figure 10), indicating the consistency and robustness of the sex-
dependent clustering patterns of the metabolic transcript profiles. Figure 9B displays 
the correlation strength of the clustering metabolic transcript profile within the same 
sex and between the opposite sexes that changed dynamically during the chemical 
perturbation period. Metabolic transcript profiles within the same sex group exhibited 
higher similarity (Spearman rank correlation) than between the opposite sexes. 
Collectively, the observed sex-dimorphic metabolic transcript profiles suggest that sex 
is a main factor that plays an important role in regulating expression of metabolic 
genes in response to various chemical perturbations. Furthermore, the correlation 
strength of the metabolic transcripts within the same sex group increases with 

















Figure 9. Hierarchical clustering of zebrafish liver metabolic transcript profiles 
at different time points in response to chemical perturbations (Spearman rank 
correlation). 
(A) Unsupervised hierarchical clustering (Spearman rank correlation) of metabolic 
transcript profiles indicates sex-dependent liver metabolic gene expression in 
response to chemical perturbation at different time points. (B) The correlation strength 
of metabolic transcript profiles within the same sex group changed dynamically 
during chemical perturbation. At different time points, the average correlation 
strength of each sex are calculated by averaging the Spearman rank correlation 
coefficients on any two metabolic transcript profiles for the respective sex. Variations 
of correlation strength on metabolic gene expression are represented by the blue curve 
for male and red curve for female. The correlation strength of metabolic transcript 
profiles between opposite sexes is represented by the black curve, which remained at 













Figure 10. Hierarchical clustering of metabolic transcript profiles at the four 
time points of chemical perturbations (Pearson correlation). 
 
4.2.3 Identification of sex-dimorphically expressed metabolic genes by a devised 
scoring scheme 
The next analysis investigated if chemical perturbations might induce converged 
metabolic states in a sex-dependent manner through common metabolic genes and 
pathways, as it has been previously reported that there is a common mechanism in 
toxicant-induced inhibition of signaling pathway [177]. In order to identify metabolic 
genes that commonly display sex-dimorphic response under different chemical 
perturbations, the sex-dependent expression score (SDES) was devised with a 
numerical value between -1 to 1 for each gene to evaluate the magnitude of gene 
response acting in opposite directions in male and female fish (for details please refer 
to section 3.4, Chapter 3). High positive SDES (0.5-1.0) indicates genes with strong 
sex-biased transcriptional activity during various chemical perturbations, i.e. these 
genes are oppositely responded to all chemical perturbations between male and 
female fish (demonstration in Figure 4A). On the contrary, negative SDES means the 
gene response is not sex-biased (demonstration in Figure 4B). The SDES for 
 
 




corresponding gene at different time point is given in Table 3, column “Sex-
dependent expression score (SDES)”. 
 
The distribution of metabolic genes according to their SDES was plotted in a 
histogram (Figure 11). It is apparent that a large number of metabolic genes were 
associated with positive SDES, suggesting their commonality in sex-dependent 
responses to chemicals. Genes with SDES higher than 0.5 were defined as those 
commonly responding to chemicals in a sex-dependent manner (the genes with SDES 
≥ 0.5 are given in Table 4). Overall, they corresponded to 5.2%, 9.8%, 11.1%, and 
10.4% of total metabolic genes in our study at 8, 24, 48, and 96 hours, respectively. 
These percentages are in good accordance with the correlation strength of metabolic 
transcript profiles within the same sex presented in Figure 9B, suggesting that the 
number of sex-dimorphically expressed genes contribute significantly in shifting the 














Figure 11. Distribution of metabolic genes according to their sex-dependent expression score (SDES). 
The histogram shows the distribution of metabolic genes according to their sex-dependent expression score (SDES) at the four time points of 
chemical perturbation. Each vertical bar represents the percentage of genes with SDES in a specific range. Genes with sex-dimorphic expression 








Table 4. Genes commonly respond to chemicals in a sex-dependent manner (sex-
















tph1a 0.724953787   ptdss1 0.823592073   acox3 0.798244992   pomt2 0.848551805 
nsd1a 0.724666932   paics 0.798931004   pip5k2 0.78033912   pccb 0.778425678 
pip5k2 0.699042612   psat1 0.758071362   pgm1 0.742160837   ptgds 0.752185774 
nudt9 0.675780906   gne 0.754897912   iars 0.741067944   impdh2 0.713206279 
hmgcl 0.662586725   me2 0.739254787   elovl6 0.73846403   gpt2 0.712944143 
wars 0.655064059   gcat 0.735363352   cpt2 0.736656504   csad 0.689920829 
amy2a 0.633846627   agpat9 0.726195791   gale 0.733262113   hsd17b4 0.659439191 
tdh 0.60945042   iars 0.704659159   ext1a 0.71350592   hsd3b7 0.655938052 
ugt1ab 0.597468654   adka 0.691424625   hs6st2 0.674828665   gclc 0.645592565 
elovl5 0.596163811   csad 0.689158335   fmo5 0.673000942   pfkfb2 0.638905788 
acsl4 0.567632879   elovl6 0.673847715   gne 0.670221262   nudt5 0.633959837 
npl 0.552712964   adob 0.667520424   pklr 0.64207083   hsd17b8 0.614277649 
itm1 0.54404157   rdh8 0.664842547   ptgds 0.641863953   polr1c 0.608759857 
pklr 0.525110227   acss2 0.661367712   uros 0.631428465   dhdds 0.606382122 
ehmt1a 0.515943418   mut 0.655666343   ctps 0.623672119   cmas 0.583591465 
sephs1 0.504989739   setmar 0.653295861   shmt2 0.619694844   pdss1 0.582844026 
  
  cox7a2l 0.645632067   mgll 0.609152275   uck2b 0.575810513 
  
  ptgds 0.6389273   csad 0.59297318   lars 0.575452253 
  
  mthfd1 0.596627366   hsd17b4 0.591975551   alg6 0.573193823 
  
  rrm2 0.585352297   acadvl 0.584254117   uqcrfs1 0.557012737 
  
  amy2a 0.581471969   polr1c 0.574184747   glo1 0.544311191 
  
  ndpkz4 0.574796596   ptdss1 0.574053331   polr3k 0.54328305 
  
  alg6 0.570143288   extl3 0.553487512   mgll 0.533569815 
  
  upb1 0.56241356   elovl5 0.54830316   gstal 0.530407954 
  
  hsd11b2 0.560509356   suv39h1a 0.543871147   idh2 0.528063355 
  
  dhdds 0.549580506   ak2 0.541428548   fpgs 0.526948491 
  
  chpt1 0.546032572   ppt1 0.540648223   aldh7a1 0.522097919 
  
  uqcrq 0.539110132   scd 0.533450425   lta4h 0.518933865 
  
  cyc1 0.517948279   polr2e 0.533079449   ass1 0.518115018 
  
  nudt9 0.514584696   gucy2f 0.527625417   gucy2f 0.517538657 
  





























To investigate whether the observed differences in gene activity between the opposite 
sexes existed under normal physiology, the comparison of the gene expression levels 
between male and female in the control (untreated) groups was carried out. The 
Student’s t-test was performed to examine the metabolic transcript profile between 
male and female fish at 8h, 24h, 48h, and 96h. The metabolic genes were then ranked 
according to their statistical significance (p-value) in decreasing order of sexual 
dimorphism (the p-value for each gene was showed in Table 3, column “p-value 
(Student’s t-test)”). The comparison of the ranked lists from the chemical treated and 
untreated groups is able to determine whether there are distinguishable sex-dimorphic 
gene expression profiles induced by chemicals. It was found that most of the top-
ranked genes expressed in the chemical treatment group (gene symbols were provided 
in Table 5) are located at the middle or the bottom of the ranked gene list in the 
untreated group (Figure 12). This further indicates that the sex-dimorphic expression 
of metabolic genes identified in the chemical treatment groups are indeed induced by 
chemical perturbations and are not merely part of the existing molecular differences 
between the two sexes. A proof of identifying chemical-induced sex-dimorphic genes 
on top of untreated controls from microarray data processing aspect is also provided 














Figure 12. Comparison of sex-dimorphically expressed metabolic genes between 
chemical treated and control (untreated) groups. 
Distribution of top ten sex-dimorphically expressed metabolic genes in response to 
chemical perturbation against ranked list of the control (untreated) groups. The top ten 









Table 5. The top 10 sex-dimorphically expressed metabolic genes in the chemical 
treated groups at the four different time points 
 8 hours 24 hours 48 hours 96 hours 
1 tph1a ptdss1 acox3 pomt2 
2 nsd1a paics pip5k2 pccb 
3 pip5k2 psat1 pgm1 ptgds 
4 nudt9 gne iars impdh2 
5 hmgcl me2 elovl6 gpt2 
6 wars gcat cpt2 csad 
7 amy2a agpat9 gale hsd17b4 
8 tdh iars ext1a hsd3b7 
9 ugt1ab adka hs6st2 gclc 
10 elovl5 csad fmo5 pfkfb2 
 
Genes commonly responding to different chemicals in a sex-dependent manner 
(SDES ≥ 0.5) and their corresponding time points are shown in Figure 13. It was 
noted that transcriptional activities of many xenobiotic metabolism related genes 
became sex-biased upon chemical perturbation, for example, fmo5 (flavin containing 
monooxygenase), aldh4a1 and aldh7a1 (aldehyde dehydrogenase), gstal (glutathione 
S-transferase), and ugt1ab (UDP glucuronosyltransferase). The cytochrome P450 
enzyme gene (cyp1a) also had a relatively high SDES score (SDES=0.414) at 24 
hours, indicating its sex-dimorphic responses to chemical treatments. Other than 
genes encoding xenobiotic metabolizing enzymes, several functionally diverse 
metabolic genes also showed sex-dimorphic responses, such as those encoding for 
ELOVL fatty acid elongase (elovl), DNA-directed RNA polymerase (polr), and 
hydroxysteroid dehydrogenase (hsd). 
 
Furthermore, among the 91 metabolic genes that showed sex-dimorphic responses 
during chemical perturbations, 21 genes (23.1%) were present at two or more time 
 
 




points and 70 genes (76.9%) were present only at one specific time point (Figure 13). 
The temporal difference in sex-dimorphic expression suggests that both time-invariant 
and time-variant sex-dependent regulations are required to fine-tune metabolic 
homeostasis upon chemical perturbations. 
 
 
Figure 13. Sex-dimorphically expressed metabolic genes in response to chemical 
perturbation at different time points. 
All sex-dimorphically expressed metabolic genes were selected based on SDES of 0.5 
or above. Genes that are sex-dimorphically expressed at one, two or three time points 
are presented in (A), (B) and (C) respectively. No gene is consistently behaved sex-









4.2.4 Synteny analysis of sex-dimorphic metabolic genes 
The synteny analysis was also performed to visualize the local distribution of these 
genes on chromosomes among these species. By considering genes located within 10 
mega bases (10 Mb) within a chromosome as adjacently localized, it was found that 
most of the sex-dimorphic genes from the zebrafish (Figure 14) were adjacently 
localized on same chromosome. This was also the same for homologous genes found 
in human (Figure 15) and mouse (Figure 16) although the gene order was slightly 
differed. In addition, several homologous genes are located on the X chromosome of 
human and mouse suggesting a possible common transcriptional regulatory 
mechanism between species. Synteny analysis thus implicates conserved functionality 
for these genes between fish and mammals although sex-dependent expression of 


















Figure 14. Local distribution of sex-dimorphically expressed genes on zebrafish 
chromosomes. 
Sex-dimorphically expressed metabolic genes from the zebrafish were adjacently 
localized within 10 mega bases on same chromosome (marking with grey 
















Figure 15. Local distribution of the homologous genes on human chromosomes. 
Homologous genes in human were adjacently localized within 10 mega bases on same 
chromosome (marking with grey background). Left column: gene symbol. Right 













Figure 16. Local distribution of the homologous genes on mouse chromosomes. 
Homologous genes in mouse were adjacently localized within 10 mega bases on same 
chromosome (marking with grey background). Left column: gene symbol. Right 












4.2.5 Identification of enriched sex-dimorphic metabolic pathways 
As the functional units of metabolic systems are composed of metabolic pathways, it 
is also interesting to identify chemical-responsive sex-dimorphic pathways. Thus, we 
compared, by gene set enrichment analysis (GSEA) [172], the ranked lists of 
metabolic genes (ranking according to sex-dependent expression score (SDES) for 
chemical-treated and p-value (Student’s t-test) for control (untreated) group) with 
defined knowledge-based gene sets in metabolic pathways available in KEGG 
database (Table 6). Metabolic pathways, that were statistically significant (nominal p-
value ≤ 0.05) and moderately (0.05 ≤ nominal p-value ≤ 0.1) enriched with sex-
dimorphically expressed genes for chemical-treated and untreated groups at four time 
points are shown in Table 7 and Table 8, respectively. The magnitude of sex-
dependent activity for each pathway was indicated by normalized enrichment score 
(NES). A metabolic pathway with positive NES implies the presence of sex-
dimorphic response during chemical perturbation. Negative NES implies no sex-
dimorphic response associated with the pathway. 
 
 
Table 6. Classification of genes into metabolic categories based on KEGG 
definition 
Metabolic Pathway Gene 
Glycolysis / Gluconeogenesis acss2, adh5, akr1a1b, aldh3a2, aldh7a1, 
aldh9a1b, aldoaa, aldoab, dlat, eno1, eno2, 
gapdh, gpia, hk1, hk2, ldha, ldhb, pgk1, pgm1, 
pklr, pkm2a, tpi1b 
Citrate cycle (TCA cycle) aco1, dlat, idh2, mdh1a, ogdh, pc, sdha, sdhb, 
sdhc, sdhda, suclg2 








Pentose and glucuronate 
interconversions 
aldh3a2, aldh9a1b, dcxr, dhdhl, rpe, ugdh, 
ugt1ab 
Fructose and mannose 
metabolism 
aldoaa, aldoab, gmds, hk1, hk2, mtmr6, pfkfb2, 
pfkfb3, pmm2, tpi1b, wwox 
Ascorbate and aldarate 
metabolism 
aldh3a2, aldh7a1, aldh9a1b, ugdh, ugt1ab 
Fatty acid metabolism acadl, acadm, acads, acadvl, acat1, acat2, 
acox1, acox3, acsl1, acsl4, adh5, aldh3a2, 
aldh7a1, aldh9a1b, cpt2, echs1, gcdh, hadh, 
hadhb 
Steroid hormone biosynthesis cyp1a, hsd11b2, hsd17b8, srd5a3, ugt1ab 
Oxidative phosphorylation atp5a1, atp5c1, atp5f1, atp5g, atp5i, atp5l, 
atp5o, atp6v0d1, atp6v1ba, atp6v1e1, atp6v1f, 
atp6v1g1, atp6v1h, cox4i1, cox5aa, cox5ab, 
cox6a1, cox7a2, cox7a2l, cox7c, cyc1, ndufa10, 
ndufa4l, ndufa6, ndufa9, ndufab1, ndufb10, 
ndufb4, ndufb5, ndufb8, ndufs1, ndufs3, ndufs5, 
ndufs6, ndufs8, sdha, sdhb, sdhc, sdhda, uqcrb, 
uqcrfs1, uqcrq 
Purine metabolism adka, adkb, ak2, ampd3, atic, fhit, gart, gmps, 
gucy2f, hprt1, impdh2, ndpkz2, ndpkz4, nme2, 
nt5c2, nudt5, nudt9, paics, papss2, pde6c, 
pgm1, pklr, pkm2a, polr1a, polr1c, polr2e, 
polr2gl, polr3b, polr3k, prps1a, rrm1, rrm2 
Pyrimidine metabolism cad, cmpk, ctps, dpyd, ndpkz2, ndpkz4, nme2, 
nt5c2, polr1a, polr1c, polr2e, polr2gl, polr3b, 
polr3k, rrm1, rrm2, txnrd1, uck2b, upb1 
Alanine, aspartate and glutamate 
metabolism 
agxtl, aldh4a1, ass1, cad, glud1b, got1, got2b, 
gpt2 
Glycine, serine and threonine 
metabolism 
agxtl, alas2, aldh7a1, cbs, cth, gatm, gcat, gldc, 
mao, psat1, shmt1, shmt2, tdh 
Cysteine and methionine 
metabolism 
ahcy, amd1, cbs, cth, dnmt1, dnmt5, dnmt7, 
got1, got2b, ldha, ldhb, mtr, sms, tat 
Valine, leucine and isoleucine 
degradation 
acadm, acads, acat1, acat2, aldh3a2, aldh7a1, 
aldh9a1b, auh, bcat1, bcat2, bckdha, echs1, 
hadh, hadhb, hibadhb, hmgcl, hmgcs1, 
hsd17b10, ivd, mut, pccb 
Valine, leucine and isoleucine 
biosynthesis 
bcat1, bcat2, iars, lars, vars 
Lysine degradation acat1, acat2, aldh3a2, aldh7a1, aldh9a1b, 
ash1l, echs1, ehmt1a, gcdh, hadh, nsd1a, ogdh, 
setd8b, setdb2, setmar, suv39h1a, suv420h1 
Arginine and proline metabolism aldh18a1, aldh3a2, aldh4a1, aldh7a1, 
aldh9a1b, amd1, arg2, ass1, ckma, ckmt1, 
gatm, glud1b, got1, got2b, lap3, mao, odc1, 
sms 
Tyrosine metabolism adh5, dbh, dct, got1, got2b, hgd, mao, mif, tat 
 
 




Phenylalanine metabolism got1, got2b, mao, mif, pah, prdx6, tat 
Tryptophan metabolism aanat2, acat1, acat2, aldh3a2, aldh7a1, 
aldh9a1b, cat, ccbl2, cyp1a, echs1, gcdh, hadh, 
kmo, mao, ogdh, tph1a, wars 
beta-Alanine metabolism acadm, aldh3a2, aldh7a1, aldh9a1b, dpyd, 
echs1, sms, upb1 
Selenoamino acid metabolism ahcy, cbs, cth, papss2, sephs1, sps2 
Glutathione metabolism gclc, gclm, gpx1a, gpx4b, gstal, gstp1, idh2, 
lap3, odc1, pgd, rrm1, rrm2, sms 
Starch and sucrose metabolism amy2a, gpia, hk1, hk2, pgm1, pygl, ugdh, 
ugt1ab 
N-Glycan biosynthesis alg1, alg2, alg3, alg6, alg9, dad1, dpm1, itm1, 
st6gal2 
Amino sugar and nucleotide 
sugar metabolism 
cmas, gale, gmds, gne, gpia, hk1, hk2, npl, 
pgm1, pmm2, uap1l1, ugdh 
Glycerolipid metabolism agk, agpat4, agpat9, akr1a1b, aldh3a2, 
aldh7a1, aldh9a1b, dgat1, lpl, mgll 
Inositol phosphate metabolism impa1, pi4kb, pip5k2, ptenb, tpi1b 
Glycerophospholipid metabolism agpat4, agpat9, chpt1, cpla2, gpd1, gpd1l, 
ptdss1, taz 
Ether lipid metabolism chpt1, cpla2, enpp6, pafah1b1b, pafah1b3 
Arachidonic acid metabolism cpla2, cyp2j22, gpx1a, lta4h, ptgds, tbxas1 
Pyruvate metabolism acat1, acat2, acss2, aldh3a2, aldh7a1, 
aldh9a1b, dlat, glo1, hagh, ldha, ldhb, ldhd, 
mdh1a, me2, pc, pklr, pkm2a 
Propanoate metabolism acadm, acat1, acat2, acss2, aldh3a2, aldh7a1, 
aldh9a1b, echs1, ldha, ldhb, mut, pccb, suclg2 
Butanoate metabolism acads, acat1, acat2, echs1, hadh, hmgcl, 
hmgcs1, wwox 
One carbon pool by folate atic, dhfr, gart, mthfd1, mtr, shmt1, shmt2 
Retinol metabolism adh5, bcmo1, cyp1a, dgat1, rdh12, rdh8, retsat, 
ugt1ab 
Metabolism of xenobiotics by 
cytochrome P450 
adh5, cyp1a, dhdhl, ephx1, gstal, gstp1, ugt1ab 
Drug metabolism - cytochrome 
P450 
adh5, fmo5, gstal, gstp1, mao, ugt1ab 
Drug metabolism - other enzymes dpyd, gmps, hprt1, impdh2, uck2b, ugt1ab, 
upb1 
Biosynthesis of unsaturated fatty 
acids 
acox1, acox3, elovl5, elovl6, fads2, ptplb, scd 








As shown in Table 7 and Table 8, enriched sex-dimorphic pathways are different 
between chemical-treated and untreated groups, suggesting that chemicals indeed 
induced different sets of sex-dimorphic pathways. As there was no feeding during the 
96-hour chemical exposure experiments for both treated and untreated groups, sex-
dimorphic pathways identified in the control (untreated) groups mainly corresponded 
to responses to non-feeding condition between males and females. Alterations of sex-
dimorphic gene expression and pathways during non-feeding or manipulation of 
dietary carbohydrate have also been observed in a previous study [178]. By 
comparing two pathway lists in Table 7 and Table 8, it was found that several 
pathways, including drug metabolism-other enzymes, biosynthesis of unsaturated 
fatty acids, fatty acid metabolism, glycerophospholipid metabolism, and purine and 
pyrimidine metabolism, showed sex-dimorphic responses only under chemical 
treatments. The enrichment of drug metabolism-related pathway at 24 and 96 hours 
indicates that a large portion of genes involving in xenobiotic metabolism responded 
differentially in male and female fish. This also suggests that zebrafish has sex-
dependent capabilities of xenobiotic detoxification under chemical treatments. As the 
sexual differences of xenobiotic metabolism has also been reported in mammals [144-
146], these observations might imply common sex-dependent xenobiotic responses 
between fish and mammals. In addition, sex hormones and other non-hormonal sex-
factors are known to regulate lipid-related and nucleotide-related metabolism [179-
181]. The relevant pathways are also sex-dimorphic under toxico-pathological 
homeostasis in our study. In view of the significance of biological functions mediated 
by these pathways during xenobiotic encountering [182, 183] it is important to 
consider the sex factor as a variable in relevant studies. 
 
 




Table 7. Sex-dimorphic metabolic pathways under chemical treatments. 
  Pathway     NES  Nominal 
                                                                                                            p-value 
  8 hours Biosynthesis of unsaturated fatty acids 1.64  0.005 
  Lysine degradation    1.44  0.034 
  Starch and sucrose metabolism  1.39  0.066 
  Tryptophan metabolism   1.33  0.099 
24 hours Glycerophospholipid metabolism  1.67  0.003 
  Steroid hormone biosynthesis  1.42  0.034 
  Glycine, serine and threonine metabolism 1.37  0.071 
  Drug metabolism – other enzymes  1.37  0.075 
48 hours Purine metabolism    1.41  0.015 
  Fatty acid metabolism   1.41  0.031 
  Amino sugar and nucleotide sugar  1.40  0.038 
  metabolism 
  Pyrimidine metabolism   1.37  0.044 
Biosynthesis of unsaturated fatty acids 1.38  0.062 
96 hours Drug metabolism – other enzymes  1.43  0.038 
  Glycerolipid metabolism   1.36  0.070 
  Pyrimidine metabolism   1.31  0.075 
Listed are significantly (nominal p-value ≤ 0.05; highlighted in bold) and moderately 












Table 8. Sex-dimorphic metabolic pathways in control (untreated) group. 
  Pathway     NES  Nominal 
                                                                                                                        p-value 
  8 hours N-glycan biosynthesis   1.40  0.052 
  Lysine degradation    1.34  0.059 
  Ether lipid metabolism   1.37  0.064 
24 hours Propanoate metabolism   1.31  0.040 
48 hours Selenoamino acid metabolism  1.51  0.009 
  Propanoate metabolism   1.39  0.018 
  Valine, Leucine and Isoleucine biosynthesis 1.33  0.070 
  Steroid hormone biosynthesis   1.32  0.074 
  Glycerolipid metabolism   1.27  0.088 
96 hours Citrate cycle (TCA Cycle)   1.52  0.005 
  Alanine, aspartate and   1.45  0.017 
  glutamate metabolism 
  Propanoate metabolism   1.38  0.025 
  Ether lipid metabolism   1.41  0.031 
  Selenoamino acid metabolism  1.37  0.044 
  Pentose and glucuronate interconversions 1.36  0.048 
  Arachidonic acid metabolism   1.34  0.067 
  Tyrosine metabolism    1.31  0.074 
Listed are significantly (nominal p-value ≤ 0.05; highlighted in bold) and moderately 










4.2.6 Network analysis revealed preferential enrichment at lipid and nucleotide 
metabolisms with prolonged chemical perturbations 
In order to understand how sex-dimorphic pathways are coordinated at the systems 
level, the zebrafish metabolic pathway network was constructed using KEGG-derived 
metabolic pathways, with minimum 5 genes detected in microarray experiments for a 
given pathway (Figure 17 – Figure 20). The resulting network consists of 41 nodes 
(metabolic pathways) and 84 edges. Two pathways are connected if a product of one 
pathway is utilized as a substrate in another pathway (for details please refer to 
section 3.6, Chapter 3). The size of each node is proportional to log10(1/nominal p-
value), where nominal p-value is the indicator of statistical significance of pathway in 
GSEA analysis, and the color denotes the normalized enrichment score (NES). A 
large red node represents statistically enriched (p-value < 0.05 in GSEA analysis) sex-
dimorphic responsive pathways, where a small node indicates the lack of statistical 
significance, and a green node means there is no sex-dimorphic response associated 
with the pathway.  
 
At early stage of chemical perturbations (8 and 24 hours), statistically enriched sex-
dimorphic metabolic pathways were distributed over various metabolic categories, 
such as carbohydrate metabolism, amino acid metabolism, lipid metabolism, and 
xenobiotics biodegradation and metabolism, as indicated by the scattered distribution 
of large red nodes all over the networks, reflecting sex-dependent response of 
numerous metabolic processes (Figure 17 and Figure 18). At late stage of chemical 
perturbation (48 and 96 hours), most significantly enriched pathways belonged to 
lipid metabolism and nucleotide metabolism (Figure 19 and Figure 20), which 
 
 




suggests that progressive chemical perturbation induced sex-dependent response on 
many specific metabolic functions rather than on broad metabolic processes as oppose 
to earlier time points. 
 
Taken together, our network analysis indicates sex-dimorphic metabolic pathways are 
differentially distributed across different functional modules during chemical 
treatments. This suggests the existence of different regulatory modes controlling the 
activities of metabolic pathways in opposite sexes during homeostatic responses to 
chemical perturbation. These sex-dependent regulations of metabolic functions can 
subsequently lead to differential cellular signaling events to regulate downstream 

















Figure 17. Network of metabolic pathways with sex-dimorphic responses to chemical perturbation in zebrafish liver at 8 hours.  
A node represents metabolic pathway and edges denote cross-talks between pathways. Size of node denotes the statistical significance (nominal 
p-value) of the metabolic pathway and color represents the normalized enrichment score (NES) score from gene set enrichment analysis (GSEA) 
analysis. The background color represents higher level of functional categories as indicated by the color code at the bottom of the figure. 
 
 






Figure 18. Network of metabolic pathways with sex-dimorphic responses to chemical perturbation in zebrafish liver at 24 hours. 
A node represents metabolic pathway and edges denote cross-talks between pathways. Size of node denotes the statistical significance (nominal 
p-value) of the metabolic pathway and color represents the normalized enrichment score (NES) score from gene set enrichment analysis (GSEA) 
analysis. The background color represents higher level of functional categories as indicated by the color code at the bottom of the figure. 
 
 






Figure 19. Network of metabolic pathways with sex-dimorphic responses to chemical perturbation in zebrafish liver at 48 hours.  
A node represents metabolic pathway and edges denote cross-talks between pathways. Size of node denotes the statistical significance (nominal 
p-value) of the metabolic pathway and color represents the normalized enrichment score (NES) score from gene set enrichment analysis (GSEA) 
analysis. The background color represents higher level of functional categories as indicated by the color code at the bottom of the figure. 
 
 






Figure 20. Network of metabolic pathways with sex-dimorphic responses to chemical perturbation in zebrafish liver at 96 hours.  
A node represents metabolic pathway and edges denote cross-talks between pathways. Size of node denotes the statistical significance (nominal 
p-value) of the metabolic pathway and color represents the normalized enrichment score (NES) score from gene set enrichment analysis (GSEA) 
analysis. The background color represents higher level of functional categories as indicated by the color code at the bottom of the figure. 
 
 






The toxicogenomic analysis in the work revealed common sex-dependent metabolic 
gene expression in response to chemical insults in the zebrafish liver. The chemical-
induced sexual dimorphism in metabolic processes can be observed not only at the 
gene and pathway level, but also at the higher network level with defined functional 
modules. Moreover, the affected sex-dimorphic metabolic pathways changed 
dynamically during the chemical perturbation period, with most genes exhibiting 
temporal sex-dependent behavior, suggesting homeostatic and feedback adjustments. 
The present findings of sex-dimorphic responses to chemical insults in male and 
female fish warrant further investigations in mammals as they may have toxicological, 
liver pathological and metabolic disorder implications. Therefore, our study 















Chapter 5 Inverted expression profiles of sex-biased genes in 




According to the study in last chapter, there are large amount hepatic genes which 
exhibit sex-dependent behavior while the host (zebrafish) is exposed to chemicals. 
The sex-dimorphic genes can be further classified into male-biased genes as those 
predominantly expressed in males and vice versa for female-biased genes. By re-
examining sex-dimorphically expressed genes (sex-dependent expression score 
(SDES) > 0.5) at multiple time-points from Figure 13, it was found that during 
chemical treatment most sex-dimorphic gene maintained its sex-biased response 
either in male or in female fish. However, there were two genes, elovl5 and dhdds, 
which changed their sex-biased responses (i.e. from male-biased to female-biased, 
and vice versa) (Figure 21). These two examples are not likely caused by fluctuations 
in experiments or statistical errors from data processing. Because according to the 
definition of SDES, the probability of getting the gene response under all four male 
conditions to one direction and to another direction under all four female conditions 
by chance is extremely small, which suggests that p-value < 0.0195 if we set the null 
model to be a random gene response to chemical insults. In addition, there was no 
sudden change of sex preference at two consecutive time points. The sex-biased 
expression of gene elovl5 and dhdds were gradually changed during the prolonged 
chemical treatment. Therefore, it is interesting to study this situation that original sex-
 
 




biased genes reverse their sex-biased profiles during chemical treatment or under 
disease conditions. The sex-reverse phenomena have been reported in some animals 
as the change of sex-specific phenotype to that of the other sex by treading with 




Figure 21. Reversed sex-biased response for gene elovl5 and dhdds under 
prolonged chemical treatment 
These genes showed sex-dimorphic response at multiple time points. Gene elovl5 
(elongation of very long chain fatty acids protein 5) changed the sex preference of 
gene expression from male-biased (8h) to female-biased (48h); gene dhdds 
(dehydrodolichyl diphosphate synthase) changed the sex preference of gene 
expression from female-biased (24h) to male-biased (96h). 
 
To investigate sex-dependency to various toxico-pathological and disease conditions, 
the zebrafish was used as a model to study sex-dependent response to toxicants. In 
 
 




addition, the transcriptome data for the association of sex to human diseases was 
retrieved from Gene Expression Omnibus. The analyses revealed striking observation 
that sex-biased genes in both zebrafish and human exhibited generally similar 
expression behavior in response to toxicological perturbations (zebrafish) and 
pathological conditions (human). Both fish and human show inverted expression 
profiles of sex-biased genes, where affected males tended to up-regulate female-
biased genes and down-regulate male-biased genes, and vice versa in affected females. 
Intriguingly, the extent of these inverted profiles also correlated well with the severity 
or susceptibility to a given toxico-pathological state, suggesting the importance of 
sex-biased genes in playing active roles in regulating normal physiological functions. 
 
5.2 Results and discussion 
 
5.2.1 Inverted expression profiles of sex-biased genes are widely observed in both 
fish and human 
In this study, our objective is to understand how sex-biased genes behave under a 
broad spectrum of toxico-pathological conditions. As shown in Figure 22, sex-biased 
genes (male-biased and female-biased) were first defined by comparison of gene 
expression between male and female control samples from various biological sources. 
Then, both up- and down-regulated male (or female)-biased genes were calculated for 
their portion in total number of male (or female)-biased genes for each toxicological 
or disease condition. For instance, for a disease state in male, its male-biased gene 
ratios that were up- and down-regulated were calculated as (Number of up-regulated 
 
 




male-biased genes)/(Total male-biased genes) and (Number of down-regulated male-
biased genes)/(Total male-biased genes), respectively. Similar approach was applied 
to females to calculate ratios of responsive sex-dimorphic genes for both male- and 
female-biased genes under each experimental condition. Finally the data are presented 
in Figure 23 for the zebrafish data and in Figure 24 for human data. As shown in 
these two figures, there were very strikingly similar inverted expression profiles of 
sex-biased genes across essentially all toxico-pathological conditions for zebrafish 
and human, i.e., affected males tended to up-regulate female-biased genes and down-
regulate male-biased genes. The opposite scenario also applied to affected females. 
 
As shown in Figure 23, fish exposed for longer duration generally had higher contrast 
(i.e. higher values of responsive ratio of sex-biased genes) of inverted expression of 
sex-biased genes than those from shorter exposure. However, fish treated for 96 hours 
generally had lower responsive ratios than those from 24 or 48 hours, which may be 
related to increased apoptosis and liver damage in 96 hours samples [185-187]. Red 
and green sample labels shown in Figure 23 indicate cases where male and female 
fish show greater ratios for inverted expression profiles, respectively. For cases where 
male fish show greater inverted expression profiles (red labels in Figure 23), 
toxicant-treated male fish tended to show higher contrasts for up-regulated female-
biased genes than toxicant-treated females for up-regulated male-biased genes. Vice 
versa is for cases where female fish showed greater inverted expression profiles 
(green labels in Figure 23). Sex-biased genes for the same sex (e.g. male-biased 
genes in males) tended to be down-regulated upon chemical treatments albeit affected 
 
 




female fish generally showed higher down-regulation ratios for female-biased genes 
than down-regulated male-biased genes in affected males. 
 
Likewise, in human pathological conditions, the contrasts of these inverted sex-biased 
gene expression profiles were correlated to the gender susceptibility of a given 
pathological condition, with higher susceptibility of males for many of these 
deleterious states, , including Parkinson’s disease, and colorectal cancers (red sample 
labels in Figure 24) [188]. This is consistent with reported studies and clinical 
observations where males have higher risk in Parkinson’s disease and colorectal 
cancer than females [188-190]. Other pathological instances such as adenoma, 
adrenocortical carcinoma, as well as aging in several brain areas (hippocampus, 
postcentral gyrus, superior frontal gyrus) also showed obvious inverted expression 
profiles in males, implicating that males are more susceptible to these pathological 
complications [159]. On the other hand, there are a number of pathological instances 
where females displayed higher contrast of inverted expression profiles (green sample 
labels in Figure 24) but they generally showed lesser ratio (contrast) for up-regulated 
male-biased genes than incidents where males exhibit greater inverted expression 
profiles (red sample labels) for ratio of up-regulated female-biased genes. This 
observation is similar to those observed in the zebrafish (Figure 23). However, there 
are incidents where females suffer higher risk. For instance, female smokers are at 
higher risk for lung cancer than male smokers [191]. Intriguingly, this is also reflected 
in Figure 24 (Airway Epithelial Cells from Smoker) with female smokers having very 








In general, both zebrafish and human data suggested association of inverted 
expression profiles of sex-biased genes to severity or susceptibility to a given toxico-
pathological instance. However, direct evidence and molecular mechanism on these 
associations to disease susceptibility and severity remain to be investigated. 
 
 






Figure 22. Procedure of analyses of sex-biased genes and their inverted 
expression patterns under different toxico-pathological conditions. 
(A) Determination of sex-biased genes. Untreated or normal males and females from 
control groups were compared for sex-dimorphically expressed genes based on p-
value < 0.01 from Student’s t-test with genes expressed at higher levels as male-
biased expressed genes and genes expressed at lower levels as female-biased 
expressed genes (for details, please refer to section 2.3.2, Chapter 2). (B) 
Identification of perturbed genes under toxico-pathological states. To assess genes 
that were affected under a given deregulated state, arrays of chemical treated or 
disease states of the same sex (i.e. male treated/diseased vs. male controls and similar 
approach for female samples) were compared using Student’s t-test. Genes showing 
p-value < 0.01 with higher and lower expressed transcripts were considered as up- 
and down-regulated, respectively (for details, please refer to section 2.3.3, Chapter 
2). (C) Calculation of responsive sex-biased gene ratios. Genes within the set of sex-
biased genes (e.g. male-biased genes) was overlapped with genes from perturbed gene 
sets to determine proportion of sex-biased genes that were significantly perturbed 
under a toxico-pathological state. Ratios for male-biased and female-biased genes are 
calculated by counting the number of affected sex-biased genes (up- and down-
regulated) with respect to total male- or female-biased genes and were compiled into 
Figure 23 and Figure 24. 
 
 






Figure 23. Inverted sex-biased gene expression profiles of the zebrafish in 
response to various chemical perturbations. 
Sex-biased genes from each experiment were determined from males vs. females of 
physiological states with p-value < 0.01 using Student’s t-test (Figure 22). Ratios of 
responsive sex-biased gene were used to represent the overall responsiveness of male-
biased and female-biased genes. Red treatment labels are males showing obvious 
inverted expression profiles than females. Green treatment labels are females showing 
obvious inverted expression profiles than males. Black treatment labels are those 
without clear inverted expression profiles. Abbreviations: Cd, cadmium (II); As, 













Figure 24. Inverted sex-biased gene expression profiles of the human under 
various pathological states.  
Sex-biased genes from each experiment were determined from males vs. females of 
physiological states with p-value < 0.01 using Student’s t-test (Figure 22). Ratios of 
responsive sex-biased gene were used to represent the overall responsiveness of male-
biased and female-biased genes. Red treatment labels are males showing obvious 
inverted expression profiles than females. Green treatment labels are females showing 
obvious inverted expression profiles than males. Black treatment labels are those 
without clear inverted expression profiles. Abbreviations: Cd, cadmium (II); As, 
arsenic (V); CA, 4-chloroaniline; NP, 4-nitrophenol. 
 
5.2.2 Sex-biased genes with frequent inverted expression under multiple 
chemical treatment conditions 
Using statistical criteria applied in this study Figure 22, 150 male-biased and 193 
female-biased genes in the zebrafish liver were obtained. Genes that were mapped to 
human homologs were submitted to WebGestalt for functional enrichment analysis 
 
 




(Table 9, 42 male-biased and 79 female-biased genes). Results shown in Table 10 
suggested distinct molecular pathways that were enriched for male and female fish. 
Male-biased functional pathways included ubiquitin mediated proteolysis, base 
excision repair, pyruvate metabolism and fatty acid biosynthesis. These processes 
were mainly involved in protein quality control, repair and energetic metabolism via 
propanoate and fatty acid metabolism. In contrast, focal adhesion as well as several 
pathways related to lipid metabolisms were enriched in female-biased processes. 
These included fatty acid beta-oxidation, nuclear receptors in lipid metabolism and 
toxicity, metabolism of lipids and lipoproteins. Additional processes such as 
integration of network metabolism and FOXA transcription network were also 
enriched in female. The enriched sex-biased pathways are shown in Table 10 
suggested there were distinct regulations between male and female in their overall 
hepatic functions, hence emphasizing again the importance of considering gender 
factor in using animal models for biomedical studies. 
 
Table 9. Sex-biased genes in the zebrafish liver 
Male-biased acaca, acss2, arpc1a, atrxl, aurkb, birc6, cdc34, cul3, dpp9, fbln1, 
flj13611, fzr1, hmgb1, hnf1b, hsbp1, igfbp1, kcmf1, lman2l, maea, 
malt1, mark2, matr3l, mkrn1, myo1e, ndpkz6, nxf1, osr1, pdlim5, 
peli3, pole3, psma4, ptrh2, rbm26, rpl21, slc13a1, spock3, stam2, 
top1l, usp7, utp20, zfr, zmym4 
Female-
biased 
abcc3, acadvl, acly, actr10, amdhd2, apeh, apool, arl6ip5, arpc1a, 
brp44, c1orf34, c3orf54, c5orf5, c6orf182, cblb, cd2bp2, cd81, 
col6a1, cpt2, cyp1a, cyp8b1, eef2l, ela1, ergic2, fam126a, fkbp8, 
gclc, gna13a, gne, gpd1b, hagh, hnf1b, hoxc11b, hsdl2, inhbb, itga2, 
itm2c, kctd1, klhl26, lasp1, lipc, lrrc8a, metap2, mgrn1, mibp2, 
mier3, mylk, ndufb8, nfat5, np, n-pac, pdcd6, per4, phyh, pkp3, 
ppp1r13b, ppp2r1a, ppp2r5e1, prodh2, ptcd2, ptp1b, rab2a, ranbp9, 
sara2, sec22ba, sec6l1, selt1b, sepp1a, serpinc1, serpind1, spag7, 








Table 10. Enriched pathways for sex-biased genes in the zebrafish liver. 
Genes mapped to human homologs were submitted to WebGestalt (for details please 
refer to section 3.5.3, and section 3.5.4, Chapter 3) to identify enriched molecular 
pathway from KEGG database [167]. Hypergeometric test with Bonferroni correction 






birc6 (baculoviral IAP repeat-containing 6); 
cdc34 (cell division cycle 34 homolog); fzr1 
(fizzy/cell division cycle 20 related 1); cul3 
(cullin 3) 
Male-biased 
Base excision repair 
hmgb1 (high-mobility group box 1); pole3 




and Fatty Acid 
Biosynthesis 
acss2 (acyl-CoA synthetase short-chain 
family member 2); acaca (acetyl-Coenzyme 
A carboxylase alpha) 
Male-biased 
Focal adhesion 
vtn (vitronectin); itga2 (integrin, alpha 2 
subunit of VLA-2 receptor); col6a1 
(collagen, type VI, alpha 1); mylk (myosin 
light chain kinase) 
Female-biased 
Fatty Acid Beta 
Oxidation 
acadvl (acyl-Coenzyme A dehydrogenase, 
very long chain); lipc (lipase, hepatic); cpt2 
(carnitine palmitoyltransferase 2) 
Female-biased 
Nuclear receptors in 
lipid metabolism and 
toxicity 
abcc3 (ATP-binding cassette, sub-family C 
(CFTR/MRP), member 3); cyp8b1 
(cytochrome P450, family 8, subfamily B, 
polypeptide 1) 
Female-biased 
Metabolism of lipids 
and lipoproteins 
abcc3 (ATP-binding cassette, sub-family C 
(CFTR/MRP), member 3); acadvl (acyl-
Coenzyme A dehydrogenase, very long 
chain); cpt2 (carnitine palmitoyltransferase 
2); phyh (phytanoyl-CoA 2-hydroxylase); 
ndufb8 (NADH dehydrogenase 
(ubiquinone) 1 beta subcomplex, 8, 19kDa) 
Female-biased 
Integration of energy 
metabolism 
np (nucleoside phosphorylase); acadvl 
(acyl-Coenzyme A dehydrogenase, very 
long chain); cpt2 (carnitine 
palmitoyltransferase 2); ndufb8 (NADH 
dehydrogenase (ubiquinone) 1 beta 





acadvl (acyl-Coenzyme A dehydrogenase, 
very long chain); vtn (vitronectin); ucp2 









Next, the sex-biased genes with frequent inverted expression across multiple 
toxicological insults were surveyed. Here sex-biased genes that significantly showed 
inverted response (p-value < 0.01) are indicated in Figure 25. In general, affected 
males showed larger number of inversely expressed female-biased expressed genes, 
i.e. up-regulating female-biased expressed genes (Figure 25B) than affected females, 
i.e. up-regulating male-biased expressed genes (Figure 25A). Results from Figure 25 
also partly supported observations shown in Figure 23. For instance, males showed 
greater inverted expression profiles in Cd 48h, As 48h, As 96h, and CA 48h (Figure 
23). This was also reflected in Figure 25B where many female-biased genes were up-
regulated. Similarly, As 24h and NP 24h were conditions where females showed 
obvious inverted expression profiles (Figure 23) also displayed greater inverted 
expression for male-biased genes shown in Figure 25A. This suggested that sex-


















Figure 25. Frequent inversely expressed sex-biased genes in the zebrafish liver 
towards toxicant treatments 
(A) Male-biased expressed genes that were inversely expressed (up-regulated) in 
affected females. (B) Female-biased expressed genes that were inversely expressed 
(up-regulated) in affected males. Sex-biased genes showing significant inverted 
expression (p-value < 0.01) to at least 4 different toxicant perturbations are considered. 
 
5.2.3 Common human sex-biased genes and their chromosomal locations 
Unlike zebrafish where only the liver was utilized to study toxicological responses, 
human transcriptome data were derived from multiple types of tissue covering 
variable diseases. Thus the common human sex-biased genes were defined based on 
their sex-dimorphic expression in at least four different tissues. The list of these sex-
biased genes is given in Table 11. There are 7 and 10 generic male-biased and 
female-biased genes, respectively. 
 
 




Most of male-biased genes are autosomal genes, except that PCDH11Y 
(protocadherin 11) is located on the Y chromosome and ASMTL (O-
methyltransferase-like acetylserotonin) on the X chromosome. However, 9 out of 10 
female-biased genes are located in the X chromosome. Interestingly, X-inactive-
specific transcript (XIST), a long non-coding RNA which is known to play a major 
role in inactivation of X chromosome [192, 193], was identified as a female-biased 
gene. Other X-linked generic female-biased genes such as zinc finger proteins ZFX 
and ZXDA, together with ribosomal protein S4 (RPS4X) and eukaryotic translation 
initiation factor 1A (EIF1AX) collectively regulated expression of female-biased 





























BIRC6 baculoviral IAP repeat-containing 6 Male-biased 2 
CS citrate synthase Male-biased 12 
GSTA4 glutathione S-transferase alpha 4 Male-biased 6 
KLK7 kallikrein-related peptidase 7 Male-biased 19 
PCDH11Y protocadherin 11 Y-linked Male-biased Y 
SEMA6A 
sema domain, transmembrane 
domain (TM), and cytoplasmic 
domain, (semaphorin) 6A 
Male-biased 5 
ARSD arylsulfatase D Female-biased X 
DDX3X 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 3, X-linked 
Female-biased X 
EIF1AX 
eukaryotic translation initiation 
factor 1A, X-linked 
Female-biased X 
HOXB2 homeobox B2 Female-biased 17 
RPS4X ribosomal protein S4, X-linked Female-biased X 
UTX 
ubiquitously transcribed 




X (inactive)-specific transcript (non-
protein coding) 
Female-biased X 
ZFX zinc finger protein, X-linked Female-biased X 
ZRSR2 
zinc finger (CCCH type), RNA-
binding motif and serine/arginine 
rich 2 
Female-biased X 
ZXDA zinc finger, X-linked, duplicated A Female-biased X 
The common sex-biased genes were defined as those genes showing sexual dimorphic 
expression to at least four different tissue types. Chromosomal location of each gene 
is obtained from Ensembl Genome Browser. 
 
Figure 26 showed responses of common sex-biased genes across different 
pathological cases. It appeared that many common male-biased expressed genes 
tended to be down-regulated in affected males than common female-biased expressed 
genes in females. Interestingly, Figure 26 suggested that males displayed higher 
tendency to exhibit inverted expression profiles (down-regulated male-biased 
 
 




expressed genes but up-regulated female-biased expressed genes) across a broad 
range of pathological conditions as compared to females. This observation 
corroborated with results showed in Figure 24 albeit the signals of inverted 
expression profiles in Figure 26 were weaker. Whether X chromosome play an 
important regulatory role in the observed inverted expression profiles of sex-biased 











Figure 26. Response of human common sex-biased genes under different pathological conditions. 
Common male-biased and female-biased expressed genes are shaded with orange and green, respectively. Genes showing significant up-
regulation (p-value < 0.01) are colored in red and blue for significantly (p-value < 0.01) down-regulated genes. Grey denotes non-significant 
response. The order of pathological labels is the same as in Figure 24. 
 
 




5.2.4 Inverted expression of sex-biased genes may be associated with reduced 
survival fitness 
It has been well recognized that sex-biased genes are important for maintenance in 
sexual reproduction and fitness [1, 49]. Thus, over-expression of sex-biased genes in 
the opposite sex can be deleterious. This notion is supported by the observation that 
male fruit flies expressing genes from female-determining genetic loci reduced male 
fitness [194]. Our analyses provided further evidence that the presence of inverted 
expression pattern of sex-biased genes in both zebrafish and human are associated to 
toxico-pathological states. Previous theoretical studies also suggested that sexual 
selection among males would reduce the equilibrium frequency of deleterious 
mutations to both sexes [2, 195]. The analyses revealed that males did generally show 
greater inverted expression profiles for sex-biased genes under various toxico-
pathological states, especially in human pathological cases (Figure 24). Whether 
these phenomena are truly correlated to evolutionary forces against selection on males 




In summary, the findings in this study of the ubiquity of inverted sex-biased 
expression profiles under diverse toxico-pathological states suggested the importance 
of sex-biased genes in normal physiological homeostasis and probably maintenance of 
sexual reproduction. Both sex-biased genes and their inverted expression profiles are 
 
 




useful for assessing biological disorders and to understand sex differences in 
pathological incidence, prevalence, and severity.  
 
 
Chapter 6 Summary and future work 
 
Although sexual dimorphism is widely recognized at various biological levels, its 
molecular basis, particularly how sex-dimorphically expressed genes behave under a 
broad spectrum of toxico-pathological states, is poorly understood. In this thesis, this 
issue is addressed by analyzing zebrafish toxicogenomic data as well as human 
pathological transcriptome data for both male and female. 
 
6.1 Major findings and contributions 
 
Zebrafish has been widely used as an important animal model for toxicological 
studies due to the ease of experimental manipulation with environmental 
contaminants. Since the sex factor plays a role in environmental adaptation, it is not 
surprising that the toxico-pathological response is biased with gender. However, there 
were limited studies to address the dynamic of sexual dimorphism in fish under 
various toxico-pathological states [178]. 
 
Other than the traditional toxicogenomic studies where the toxicology of specific 
compounds is being investigated (e.g. adsorption, distribution, metabolism, excretion 
& toxicity), by applying existing bioinformatics tools and self-devised algorithms to 
examine several microarray datasets this meta-analysis study identified metabolic 
gene expressions and pathways that display sex-dimorphic response in the zebrafish 
 
 




liver that are ‘commonly’ induced by different chemical perturbations. This indicates 
that the toxic effects from various chemicals could converge to same common sex-
dependent toxico-pathological states [177], which implies the potential of ‘common’ 
therapeutic approach for a given sex, and also indicates the importance of involving 
sex in biomarker selection [114]. 
 
Apart from well-documented sex-dependent activities of genes directly related to 
xenobiotic metabolism [62, 63, 144-146], many functionally diverse metabolic genes 
also showed sex-dimorphic responses to chemicals. Although a broad range of genes 
has been reported as sex-dimorphically expressed under normal physiology [52], the 
comparison between liver metabolic gene transcript profiles in control groups 
(untreated) and in chemical-treated conditions indicated that a large proportion of 
sexually dimorphic genes identified under chemical perturbation are in fact 
chemically induced. In other words, there are two different sets of sex-dimorphic 
genes under chemical exposure and normal physiology. Furthermore, the chemical-
induced sexual dimorphism in zebrafish hepatocellular metabolism can be observed 
not only at the transcriptome level, but also at pathway and higher network level with 
defined functional modules. The pathway and network analysis indicated that sex-
dimorphic metabolic pathways are differentially distributed across different functional 
modules during chemical treatments. Therefore sexual dimorphism might occur on 
every hierarchy of the activities within the cell. Moreover, the affected sex-dimorphic 
metabolic pathways changed dynamically during the chemical perturbation period, 
with most genes exhibiting temporal sex-dependent behavior, suggesting homeostatic 
and feedback adjustments. 
 
 




The sex factor is also indicated in conferring the diversity of human diseases in the 
appearance, susceptibility, and severity to male and female. Examples are tuberculosis 
[196], hepatitis C virus infection [197], schizophrenia [198], rheumatoid arthritis 
[199], and heart disease [138, 200, 201]. Therefore in addition to the zebrafish 
toxicogenomic data, human pathological transcriptome data were also analyzed for 
the responses of male- and female-biased genes, with male-biased genes defined as 
those predominantly expressed in males and vice versa for female-biased genes. The 
analyses revealed obviously inverted expression profiles of sex-biased genes, where 
affected males tend to up-regulate female-biased genes and down-regulate male-
biased genes, and vice versa in affected females, in a broad range of toxico-
pathological conditions. Intriguingly, the extent of these inverted profiles correlated 
well to the severity of toxico-pathological states, suggesting that inverted expression 
profiles of sex-biased genes can be used as important indicators to access biological 
disorders. 
 
In summary, the findings in this thesis revealed common sex-dependent metabolic 
gene expression in response to chemical insults in the zebrafish liver and the ubiquity 
of inverted sex-biased expression profiles under diverse toxico-pathological states in 
both fish and human. This indicates the changes in sex-dimorphic gene expression are 
likely to be a major contributor to adaptive divergence between species responding to 
stresses, which suggest the importance of sex-dimorphic genes in regulating normal 
physiological homeostasis. Both sex-biased genes and their inverted expression 
profiles are thus invaluable markers that may be used to access pathological disorders 
 
 




and to understand sex differences in incidence, prevalence, and severity for a given 
disease. 
 
6.2 Limitations and suggestions for further study 
 
In this thesis, the ubiquitous phenomenon of sex-dimorphic response of gene and 
pathway under toxico-pathological states is reported. However, the underlying 
regulatory mechanisms are still unclear. Understanding those mechanisms is crucial 
since it may not only offer clues for revealing the mystery of sexual evolution but also 
play a key role in curing diseases with sex-biased basis. To achieve this, an important 
step for further study is to differentiate the effects imposed by different sex-related 
factors which include sex hormones, sex-biased gene expression, and even the 
epigenetic differences between the two sexes. Because sex differences are created by 
intricate interactions among numerous biological and environmental cues, it becomes 
a challenge to decipher sex-dependent factors that regulate both physiological and 
pathological conditions. 
 
Furthermore, there is increasing evidence indicating that thousands of genes show 
significant differences in gene expression between the two sexes in gonadal and 
somatic tissues examined, such as liver [202, 203], kidney [64], lacrimal gland [204], 
brain [205, 206], and adipose tissue [52]. Besides, these sex-dimorphic genes also 
exhibited tissue-specific expression [52]. Hence, further systematic investigations are 
required to explore sex-dimorphic responses at the cellular level in other tissues under 
 
 




toxico-pathologic states. By comparing sex-specific effects across tissues, we can 
build on knowledge of sex differences in various systems to better understand how 
sex differences exert their impacts in the entire organism. 
 
Most importantly, despite well recognized differences between males and females in 
their pharmacokinetics and pharmacodynamics response to drugs [207], the sex factor 
is rarely considered in the whole drug discovery pipeline up to clinical trials [208]. 
Women are generally underrepresented in biomedical research [209, 210]; 
consequently, women experience 1.5 times higher risk than men in developing 
adverse drug reactions [211]. More research is needed on sex differences and 
similarities in exposure and response of mammals to xenobiotics, including 
pharmaceuticals. Therefore, current findings for the presence of chemical-induced 
sex-dimorphic responses in male and female fish warrant further investigations using 
mammals in order to better model phenomena observed in fish that will ultimately 
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Appendix A Wet lab experimental protocol 
 
Zebrafish as a model animal in toxicological studies 
The zebrafish (Danio rerio) has been used as an important model for investigating 
vertebrate development [212], toxicology and toxicologic pathology research [185, 
187, 213-215], and even understanding human diseases [166, 216, 217]. Due to the 
close physiological relationship with the environment and its high sensitivity to 
environmental changes, zebrafish has served as a useful sensor to detect hazard 
environmental pollutants. In addition, the impact of chemical effects on the fish 
system is far more easily defined and more readily studied than on terrestrial species 
[218]. 
 
The near-completed zebrafish genome project ensures zebrafish has the most 
complete database on genomics, molecular genetics and embryology among fish 
species. In addition mutant lines of zebrafish can help clarify the roles of specific 
genes and their associated signaling pathways and networks in the pathogenesis of 
toxicant-induced lesions which can be produced more efficiently and cheaply in 
zebrafish than in rodents. Most importantly, the long history of zebrafish in 
toxicology studies also provides good experimental and literature backgrounds for 
investigating sex-dimorphic difference in detoxification mechanisms. 
 
Fish possess most of the tissue types of mammals except breast, prostate and lung. 
Various studies have shown that zebrafish responded biologically to chemicals, such 
 
 




as small molecules, drugs and environmental toxicants, in a similar manner as 
mammals [166, 219, 220]. These physiological and molecular similarities in 
xenobiotic metabolism and adaptive response to toxicant insult between zebrafish and 
mammal renders zebrafish a suitable toxicology model. 
 
Zebrafish used in this thesis 
Adult zebrafish (6 months – 1 year old) were obtained from a local fish farm. The fish 
were allowed to acclimatize in aquaria for several days before transferred into smaller 
tanks for chemical exposure. Male and female fish were distinguished based on 
typical morphological differences including the size/shape, body coloring, abdomen 
etc. [221]. The gonads were also readily distinguishable by the naked eye during 
sampling of the liver tissues. All experimental protocols were approved by 
Institutional Animal Care and Use Committee (IACUC) of National University of 
Singapore (Protocol 079/07). 
 
Chemicals used, their basic property, and chemical toxicity 
The chemicals used in this thesis include two heavy metals (Cadmium, Arsenic) and 
two organic (aromatic) compounds (4-chloroaniline, 4-nitrophenol). These chemicals 
were chosen because they serve as representatives of selected environmental toxicants 
that are potential health hazards to various organisms including humans, hence having 









Cadmium (Cd) is a heavy metal which is widely found in the environment. The 
extraction, foundry, metallurgical, electroplating industries are the main sources of 
environmental pollution and occupational exposure to cadmium [222]. Cadmium can 
also expose to general public while eating the contaminated foods or contacting with 
consumer products containing this metal [222, 223]. Considering its wide usage in 
industry and a relatively long residence time in the eco-systems, the chance of 
cadmium exposure to human beings is greatly increased and therefore imposes serious 
problem to public health [224]. The human health problems which relate to cadmium 
exposure include the renal pathologies, osteoporosis, leukemia, and hypertension 
[225]. Even the chronic exposure to low level of cadmium can result in kidney and 
liver damage which has been linked to neoplastic disease and ageing [226, 227]. Not 
only accumulating in human organs, cadmium also invades circulation system and is 
associated with nucleated blood cells and lymphocytes [228, 229]. Cadmium at low 
and high concentration has been evidenced to induce apoptosis and necrosis to human 
T cell line CEM-C12 cells [224]. This might be the underlying mechanism of 
cadmium induced lymphocyte damage in vivo. Thus, cadmium has been regarded as a 
potential health threat to human and wildlife species [230, 231]. 
 
Arsenic (As) is a ubiquitous environmental toxicant widely found in atmosphere and 
aquatic system. It has been used in agricultural products such as herbicides, fungicides, 
wood preservative, and in the foundry industry [232, 233]. The combustion of fossil 
fuels has been reported to be a main source of environmental arsenic pollution [232]. 
Furthermore, arsenic pollution has also been found in drinking water in some areas 
[234]. The risk of arsenic toxicity to humans is a public health issue. Acute poisoning 
 
 




of arsenic causes symptoms such as nausea, vomiting, diarrhoea, psychosis, peripheral 
neuropathy, and skin rash [235]. Several human diseases such as blackfoot disease, 
atherosclerosis, hypertension, diabetes mellitus, skin lesions, and liver injury, in partly, 
is associated with ingestion of arsenic polluted food and drink water [143, 236-240]. 
Study found that long time arsenic-treatment to zebrafish induced abnormal 
transcriptional activity and caused cellular injury in the liver [185]. In addition, 
evidences from several epidemiological studies revealed associations of arsenic 
exposure with cancers in lung, bladder, kidney, and liver, which suggested arsenic 
should be classified as a human carcinogen [234, 241]. 
 
4-Chloroaniline is an organochlorine compound and widely used in the chemical 
industry for the production of pesticides, herbicides, drugs, and dyestuffs [242]. It is a 
precursor to the widely used antimicrobial and bactericide chlorhexidine. The way 
and places of considerable usage of 4-Chloroaniline suggest the exposure potential to 
practitioners in relevant industries. Because 4-Chloroaniline can be released as the 
degradation product from herbicides and pesticide, it is also potential to contaminate 
food [243]. Short-term exposure to 4-Chloroaniline results in cyanosis to human 
beings [242]. The dermal and inhalation exposure to 4-Chloroaniline dust and aerosol 
can lead to life-threatening methemoglobinemia [244-247]. In addition, 4-
Chloroaniline has been reported to exert the toxicity to the haematopoietic system 
[243]. It is also considered to be carcinogenic in male rats by increasing the 
incidences of sarcomas of the spleen, and in male mice by increasing the incidences 
of hepatocellular neoplasms, haemangiosarcomas of the liver or spleen [243, 248]. 
 
 




4-Nitrophenol is a common environmental pollutant owing to its wide application in 
pharmaceuticals, explosives, dyes and agrochemicals [249, 250]. 4-Nitrophenol is 
also a degradation product of the insecticide parathion [251] and a component of 
diesel exhaust particles. Accumulation of 4-Nitrophenol in air [252], soil, and water 
[253] could induce serious health problem to human and wildlife. 4-Nitrophenol is 
reported to be an endocrine disrupting chemical. It has affinity with estrogen and 
androgen receptor that exhibits estrogenic and anti-androgenic activity for both in 
vitro (a recombinant yeast screening assay) [254] and in vivo system (immature rat 
uterotrophic and Hershberger assays) [255]. 
 
Chemical treatment of zebrafish 
Adult male and female fish were treated in separate tanks. In each chemical treatment, 
60 male and 60 female fish were maintained at a density of one fish per 200 ml for 
sampling at four time-points (8-hour, 24-hour, 48-hour, and 96-hour). As the liver is a 
major organ in metabolism, the fish were not fed throughout the experiments in order 
to minimize interfering effects due to food metabolism that could confound metabolic 
responses elicited by chemicals. For each time-point group, 3 pooled liver samples 
were obtained with each pool containing livers from 4 individual fish, hence 12 fish 
were used for biological samples in each time-point group and a total of 48 fish were 
used for each chemical treatment for one sex. Concentrations of chemicals and 
number of replicates used are presented in Table 1 (also including number of 
replicates of each experiment, and the accession of the microarray data). The 
concentrations of the chemical used in the study caused 10-20% mortality based on 
96-hour acute toxicity tests carried out under similar conditions. The concentrations of 
 
 




the chemical used in the study caused 10-20% mortality based on 96-hour acute 
toxicity tests carried out under similar conditions. The concentrations were chosen as 
they were sufficient to induce toxicity with minimal mortality (10-20%), hence 
leaving enough samples for the microarray experiments. Further details of chemical 
treatments had been described in previous works [186, 214, 256, 257]. 
 
Oligonucleotide chips, material preparation, and microarray experiments 
DNA microarray technology used for examining zebrafish hepatic gene expression in 
this thesis is oligonucleotide chip. The probes in oligonucleotide chip are sets of short 
oligonucleotides that are distributed across the corresponding gene sequences [258]. 
These oligonucleotides are synthesized in a highly specific manner at defined location 
using a photolithographic procedure [259]. The sample mRNAs are labeled with 
fluorescent materials and hybridized with probes. After hybridization, the detection of 
the signals is performed by scanning device and the measured intensity for the 
represented gene is summarized across different probes in the probe set. 
 
Total RNA was extracted using Trizol reagent (Invitrogen, USA) according to the 
manufacturer's instructions. Reference RNA for microarray hybridization was 
obtained by pooling total RNA from whole adult male and female zebrafish at 9:1 
ratio. The 9:1 male:female ratio was used to reduce some of the highly abundant 
female RNA transcripts (e,g, vitellogenin) which otherwise could easily saturated the 
hybridization signals on these feature probes by the reference RNA alone. Here, a 
common reference design in a two-color dye microarray system was used and it was 
found that a 9:1 male:female ratio were able to provide sufficient reference 
 
 




hybridization signal with minimal saturated feature probes on the arrays [166]. The 
integrity of RNA samples was verified by gel electrophoresis, and their concentrations 
were determined by UV spectrophotometer. Reference RNA was co-hybridized with 
RNA samples either from chemically treated or control fish on a glass array spotted 
with 16.5K zebrafish oligo probes. Both reference and sample RNAs were reverse-
transcribed and labeled differently using fluorescent dyes Cy-3 or Cy-5. After 
hybridization at 42ºC for 16 hours in hybridization chambers, the microarray slides 
were washed in a series of washing solutions (2X SSC with 0.1% SDS; 1X SSC with 
0.1 % SDS; 0.2X SSC and 0.05X SSC; 30 seconds each), dried by low-speed 
centrifugation and scanned for fluorescence detection using the GenePix 4000B 













Appendix B FORTRAN script for calculating SDES 
!  Console3.f90  
! 
!  FUNCTIONS: 






!  PROGRAM: Console3 
! 


























 do while(.true.) 
  read(101,"(A300)",iostat=status)temp 
  if(status.ne.0)exit 
 
  do i=1,300 
   if(ichar(temp(i:i)).eq.9.or.temp(i:i).eq." ")exit 
  enddo 
  mark=i 
  name="          " 
 
 




  name(1:mark-1)=temp(1:mark-1) 
 
  sum=0 
  do i=mark+1,300 
   if(ichar(temp(i:i)).eq.9.or.temp(i:i).eq." ")then 
    sum=sum+1 
    read(temp(mark+1:i-1),*)value(sum) 
    mark=i 
   endif 
 
   if(sum.eq.group1+group2)exit 
  enddo 
 
  do i=1,group1+group2 
   
   if(i.le.group1)then 
    
    a=0 
    do j=1,group1 
     if(j.ne.i)then 
      a=a+abs(value(i)-value(j)) 
     endif 
    enddo 
    if(group1.eq.1)then 
     a=0 
    else 
     a=a/(group1-1) 
    endif 
    
    b=0 
    do j=group1+1,group1+group2 
     b=b+abs(value(i)-value(j)) 
    enddo 
    b=b/group2 
 
   else 
 
    a=0 
    do j=group1+1,group1+group2 
     if(j.ne.i)then 
      a=a+abs(value(i)-value(j)) 
     endif 
    enddo 
    if(group2.eq.1)then 
     a=0 
    else 
     a=a/(group2-1) 









    b=0 
    do j=1,group1 
     b=b+abs(value(i)-value(j)) 
    enddo 
    b=b/group1 
 
   endif 
   if(name.eq."C01308")write(*,*)"b",b,"a",a 
   SI(i)=(b-a)/max(a,b) 
 
  enddo 
 
  multiply=0 
  do i=1,group1+group2 
   multiply=multiply+SI(i) 
  enddo 
 
  count1=0 
  do i=1,group1 
   count1=count1+SI(i) 
  enddo 
  count2=0 
  do i=group1+1,group1+group2 
   count2=count2+SI(i) 
  enddo 
 
  posi1=0 
  do i=1,group1 
   if(SI(i).gt.0)posi1=posi1+1 
  enddo 
  posi2=0 
  do i=group1+1,group1+group2 
   if(SI(i).gt.0)posi2=posi2+1 
  enddo 
 











    end program Console3  
  
 
Appendix C Proof of identifying chemical-induced sex-
dimorphic genes on top of untreated controls 
 
One concern of this study is that the observed sexual dimorphism is not due to 
chemical treatment.  However, it can be demonstrated that the data processing and 
analysis methods used in our study, as shown in Figure 27, can automatically 
eliminate this situation. 
 
Assuming one gene has sex-dependent expression in control group (the gene is 
female-biased in Figure 27) and the chemical treatment does not affect or just has 
very little impact on its expression between two sexes. Under this scenario, p-value 
will approach to 1 when statistical test (Student’s t-test in our study) is used to detect 
the difference of gene expression under chemical treatment and control (untreated) 
groups. It means that the transformation log(1/ ) ~ 0p value which indicates that 
there is no opposite transcriptomic response in male and female. Therefore, gene 
demonstrated here will not be considered as chemical-induced sex-dimorphic gene, 
although it is female-biased gene in control (untreated) group. 
 
On the other hand, sex-biased genes in control group also can be considered as 
chemical-induced sex-dimorphic gene as long as the chemical exposure causes these 
genes to respond in opposite directions between two sexes. 
 
 





Figure 27. Demonstration of subtracting the sex-dimorphic background of gene 
expression in control (untreated) group from chemical-induced sex-dimorphic 
responses 
